SONO TEK CORP
10-K, 1999-06-01
SPECIAL INDUSTRY MACHINERY, NEC
Previous: SEI INSTITUTIONAL MANAGED TRUST, N-30D, 1999-06-01
Next: FIRST DEARBORN INCOME PROPERTIES LP, 10-Q, 1999-06-01




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-K

                  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: February 28, 1999

Commission File Number: 0-16035

                              SONO-TEK CORPORATION
             (Exact name of Registrant as Specified in its Charter)

         NEW YORK                                       14-1568099
(State or other Jurisdiction of            (IRS Employer Identification Number)
Incorporation or Organization)

     2012 Route 9W, Bldg. 3, Milton, New York                 12547
     (Address of Principal Executive Offices)               (Zip Code)

Registrant's Telephone Number, Including Area Code:  (914) 795-2020

Securities Registered Pursuant to Section 12(b) of the Act:  None

Securities Registered Pursuant to Section 12(g) of the Act:
                                                    Common Stock, $.01 par value
                                                            (Title of Class)

         Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
Registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days. X Yes __ No

         Indicate by check mark if disclosure of delinquent  filers  pursuant to
Item 405 of Regulation S-K is not contained  herein,  and will not be contained,
to the best of  Registrant's  knowledge,  in  definitive  proxy  or  information
statements  incorporated  by  reference  in Part  III of this  Form  10-K or any
amendment to this Form 10-K. [ ]

         As of May 28,  1999 the  aggregate  market  value  of the  Registrant's
Common  Stock  held  by  non-affiliates  of  the  Registrant  was  approximately
$1,225,300  computed by  reference to the average of the bid and asked prices of
the Common Stock on said date, which average was $0.30.

         The Registrant had 6,281,667  shares of Common Stock  outstanding as of
May 28, 1999.
<PAGE>
                                     PART I
ITEM 1   Business

(a)      General Development of Business.

Sono-Tek  Corporation (the "Company" or "Sono-Tek") was incorporated in New York
on March 21, 1975 for the purpose of engaging in the  development,  manufacture,
and sale of ultrasonic liquid atomizing nozzles.  Ultrasonic nozzles atomize low
to medium  viscosity  liquids by converting  electrical  energy into  mechanical
motion in the form of high frequency (ultrasonic) vibrations which break liquids
into minute drops that can be applied to surfaces at low  velocity.  The Company
is continuously  striving to improve the performance and versatility of its line
of ultrasonic nozzles, as well as searching for new industry applications.

During  Fiscal  1999,  the Company  signed an  agreement  with a large  European
manufacturer  of  pressure  nozzles  to  begin  selling  the  Company's  line of
ultrasonic nozzles from its sales offices  throughout Europe,  South America and
Asia.

The  Company's  SonoFlux  System,  which  applies a uniform  coating  of flux to
printed  circuit boards  immediately  prior to the components  being soldered in
place,  was introduced to the market in 1991 and has become an industry  leading
product.

During Fiscal 1998,  the Company  developed  and announced a complete  family of
liquid delivery  products  including a Gravity Feed System,  a Syringe Pump, and
multiple  models of Gear Pumps and Pressure  Reservoirs.  These liquid  delivery
products enable  customers to purchase a complete,  fully  integrated and tested
spray  solution from a single  supplier.  Also during  Fiscal 1998,  the Company
announced the MCS Infinity  System which is a precise,  highly  efficient  spray
coating system designed for general top-down spraying applications,  and the MCS
Accu Mist  System  which  provides  the  ability to spray  liquids to very small
areas, either as discrete dots or continuous lines.

During Fiscal 1999,  Sono-Tek also began  distributing in the U.S. market a full
range of pressure nozzles manufactured by a European company. Sono-Tek currently
generates the majority of its revenues from sales of capital equipment, which is
expensive and seldom  requires  replacement.  Sales of pressure  nozzles  differ
because  they are  commodity  items,  relatively  inexpensive,  and  generate  a
continuous source of revenue because of their limited useful life.

On March 3,  1999,  as part of the  Company's  plan to grow and  diversify,  the
Company signed a non-binding letter of intent to acquire a local manufacturer of
specialty equipment that produces cleaning,  degreasing and vapor drying systems
for the  semiconductor,  disk drive, and other high technology  industries.  The
Company  believes  this  acquisition,  if  consummated,   would  complement  the
Company's core business including industry focus and manufacturing similarities.
The Company also believes  that  significant  efficiencies  could be realized by
integrating  the  operation  of  the  two  companies.  The  Company  anticipates
reporting  this  transaction  on Form  8-K upon the  execution  of a  definitive
acquisition agreement.

On May 5, 1999, the Company released a Private Placement  Memorandum to sell via
a private placement 1,666,667 shares of the Company's common stock at a purchase
price of  $0.30  per  share  contingent  upon  consummation  of the  acquisition
described above.  The proceeds from this private  placement will be used to fund
the Company's  acquisition as mentioned above, and for working capital purposes.
In the event that the acquisition is not  consummated,  no shares will be issued
and all funds will be refunded to the  purchasers.  The shares sold  pursuant to
this private placement will not have been registered under the Securities Act of
1933, and may not be offered or sold in the United States absent registration or
an applicable exemption from registration  requirements.  In connection with the
private placement,  the Company has agreed to use its reasonable best efforts to
cause the purchased shares to become  registered under the Securities Act within
180 days of purchase.

(b)      Financial Information about Industry Segments.

During  Fiscal 1999 the Company was engaged in one industry  segment and line of
business.  All the products manufactured by the Company are based on the process
of ultrasonic spraying.

(c)      Description of Business.

Background

The Company is engaged in the development,  manufacture,  and sale of ultrasonic
liquid atomizing units consisting of a nozzle based on patented  technology,  an
electrical  power supply,  and related  hardware  which  atomizes  low-to-medium
viscosity liquids used in various spraying applications.

Ultrasonic  nozzles  break the  liquid  stream  into a spray of minute  drops by
intense ultrasonic vibrations  concentrated on the head of the nozzle called the
"atomizing  surface".  The Company  manufactures nozzles with atomizing surfaces
that  produce  spray  shapes  to meet  individual  customer  specifications.  In
addition,  nozzles are made in different sizes and configurations to accommodate
various flow rates and to meet the requirements of specific applications.

Ultrasonic  nozzles produce a soft low-velocity  spray of liquid which virtually
eliminates  overspray,  thereby  minimizing  waste  and loss to the  surrounding
environment.  Ultrasonic  nozzles  are  capable of  spraying  material in minute
amounts on the order of one-millionth of a liter of liquid per second.

Ultrasonic  nozzles  typically  have  large  passageways  which  makes them more
resistant to clogging.

Marketing Overview

The SonoFlux  System  accounted for  approximately  71% of the  Company's  sales
during Fiscal 1999, 76% during Fiscal 1998,  and 66% during Fiscal 1997.  Nozzle
systems  accounted  for 18%,  21% and 34% of sales,  during  those  same  years,
respectively.  Sales of the MCS Systems accounted for 9% of the Company's sales
during Fiscal 1999, and 3% during Fiscal 1998. No single customer  accounted for
more than 10% of net  sales in Fiscal  1998 and  1997.  During  Fiscal  1999 one
customer, Delco Electronics, accounted for 17% of net sales.

The  Company  markets  ultrasonic  nozzles to  customers  requiring  specialized
applications  of  liquids  to their  products.  A  majority  of sales  leads are
generated via direct mail advertising,  advertisements and technical articles in
trade  journals,  product  news  releases,  participation  in  trade  shows  and
seminars,  and by responses to the Company's website.  The majority of sales are
made to end users who use  ultrasonic  nozzles in the  manufacture  of their own
products,   to  original  equipment   manufacturers   ("OEMs")  who  incorporate
ultrasonic  nozzles  into their own  products  for  resale,  and to  government,
university,  and  private  laboratories  who use  nozzle  systems  for  research
projects. The sales function of the Company's products is currently performed by
six people located in the Company's facilities in Milton, New York.

The market for the  SonoFlux  product  line is the Printed  Circuit  Board (PCB)
assembly  industry.  For this product line, the Company utilizes the services of
independent Manufacturer's  Representatives ("Reps") in North America to augment
its internal direct sales force.  These Rep  organizations are paid a commission
on sales after the  Company  receives  payment  from the  customer.  The Company
currently has seventeen  such Rep  organizations  under contract with a total of
approximately forty people performing direct sales.

In foreign markets, the Company uses Distributors to market the SonoFlux product
line in certain European and Far Eastern  countries.  The Company  currently has
six such Distributor companies under contract.

Initial  sales of the MCS Accu Mist  and  MCS Infinity  Systems were made during
Fiscal 1998 to companies  for general  top-down  spraying  applications.  During
Fiscal  1999 sales were made into  applications  such as BGA  fluxing,  spraying
perfumes  onto  non-woven   fabrics,   spraying  a  mold  release  agent  for  a
manufacturer of filters, and spraying plastic spheres used in the manufacture of
touch-screens for flat panel displays.  All MCS Systems consist of (i) a control
module which provides  power to the  ultrasonic  nozzle,  liquid  delivery,  and
electronic control and interface functions, (ii) an ultrasonic nozzle, and (iii)
a vertical  jet  assembly  which is  available  in a wide  variety of designs to
accommodate  various spray widths.  Each module is capable of spraying  areas as
narrow as 0.25  inches or as wide as one foot.  Areas  greater  than one foot in
width can be  accommodated by grouping  together as many  individual  modules as
necessary. The Company anticipates this product will satisfy the requirements of
a broad range of industrial applications.

In January 1998,  the Company  signed a  distribution  agreement with a European
company and its subsidiaries in eleven countries covering parts of Europe,  Asia
and South  America,  to market and sell all  Sono-Tek  product  lines except the
SonoFlux  System.  There were  approximately  $36,000 in sales made through this
company in Fiscal 1999.

Markets for the Company's Products

Nozzle Systems

The  Company  markets  ultrasonic  nozzles to  customers  requiring  specialized
applications of liquids to their products such as applying  chemicals on silicon
wafers in the production of integrated circuits,  applying biochemical compounds
to medical devices, spray drying of ceramics, lubrication,  moisturization,  and
application of protective coatings to float glass.

The Company works with potential  customers in industries  which it believes can
benefit from ultrasonic  nozzles to meet specialized  application  requirements.
The Company has been concentrating its efforts on establishing its presence in a
number  of  different  markets.  (See  "Product  Development").  Currently,  the
Company's  principal  markets  for its  products  are in the  medical  products,
semiconductor manufacturing and electronics fabrication industries.

SonoFlux System

The  SonoFlux  System is  attractive  to the  electronics  industry  because  it
significantly reduces the amount of flux consumed, the related emission of these
materials to the environment, and the cost of disposing of waste flux.

MCS Infinity and MCS Accu Mist Systems

The MCS Infinity System is targeted for markets where surface areas ranging from
several inches up to several feet need to be coated with a precise, low velocity
spray.  The initial  markets being  targeted for this system  include  non-woven
fabrics,  flat panel  display  manufacturing,  and the  spraying of mold release
agents.

The MCS Accu Mist System is targeted  for markets  where the surface  area to be
coated is generally  small,  as low as a quarter of an inch.  The initial market
being targeted for this system involves the application of liquid solder flux to
individual leads or connectors used in specialized electronic assembly areas.

The initial  shipment of the  Sono-Tek's  MCS Infinity  System  occurred  during
Fiscal 1998.

Pressure Nozzles

During Fiscal 1999, the Company began distributing  pressure nozzles in the U.S.
market.  These  nozzles are  manufactured  by a leading  European  developer and
manufacturer.  Sales of pressure nozzles, which require frequent replacement and
are relatively  inexpensive,  will help diversify the Company's product line and
complement Sono-Tek's sales of capital equipment.

Product Development

For the Fiscal  years ended  February  28,  1999,  1998,  and 1997,  the Company
expended  approximately  $488,000,  $410,000,  and  $369,000,   respectively  on
research and  development.  In addition to  continuous  improvement  programs on
nozzle  systems and the  SonoFlux  9500,  these  expenditures  were  incurred to
develop (i) a photoresist  application  system for the  semiconductor  industry,
(ii) the MCS Accu Mist  and  MCS Infinity  Systems,  (iii) and a range of liquid
delivery  systems  including a Gravity Feed System, a Syringe Pump, and multiple
models of Gear Pumps and Pressure Reservoirs.

Management  believes that the Company's long-term growth and stability is linked
to the  continuous  development  and  release of  products  that  provide  total
solutions to customer  needs across a wide spectrum of  industries,  and advance
the utility of the Company's core technology.

Nozzle Products

During the third  quarter of Fiscal  1997,  the Company  introduced  a new power
supply,  the Broadband  Ultrasonic  Generator,  or the "BUG".  This power supply
provides a stable, frequency-locked electrical signal to the attached ultrasonic
nozzle and is capable of driving all of the Company's nozzles.

SonoFlux System

The SonoFlux 9500 is based on the industry  proven design  utilizing  Sono-Tek's
patented spray assembly with a stationary ultrasonic nozzle and spray dispersion
mechanism.  This  well-established  technology has been combined with a flexible
programmable  logic controller to monitor and control all system functions.  Any
system parameter is easily changed using an operator keypad and LCD display. The
controller  also  provides  visual and audible  warnings  for system  errors and
alarms.

The unit can be programmed by a user  friendly  Windows  program from a personal
computer and has the capacity to store up to 250 customized programs.

Several  SonoFlux 9500 models are available  including units for retrofit inside
wave soldering  machines,  stand alone units for assembly around existing finger
or  pallet  conveyors,  stand  alone  units  complete  with  integral  chain/tab
conveyors and configurations capable of operating in an inert environment.

During  Fiscal  1997,  the  SonoFlux  System  was  tested  and  certified  by an
independent  testing  laboratory.  The system passed all of the safety and other
tests required to be "CE"  compliant,  which is a prerequisite  to sell into the
European market.

MCS Accu Mist System

The continuing  growth of surface mount  technology in the  electronic  assembly
industry has created a need for an effective  method of applying  liquid  solder
flux only to selected portions of a PCB assembly.  This technique is referred to
as  selective  soldering.  In  addition  to  applying  flux  selectively  to PCB
assemblies,  there are other  applications that can benefit from this technique.
These  include  ball-grid  arrays,  flip-chips,  and a variety of  tape-and-reel
configurations.

The Company recognized the need to target the emerging industry  application for
selective  soldering,  and in Fiscal 1998,  released the MCS Accu Mist System to
address this need. The MCS Accu Mist  incorporates an ultrasonic nozzle designed
for low flow rates,  together  with a  spray-shaping  device to gently shape the
spray  from the nozzle  into a  precisely  defined  pattern  whose  width can be
adjusted from 0.070 to 0.250 inches.  Other  attractive  features of this system
are that it is a  non-contact  process,  and because of its  low-energy  nature,
fragile  components  are  completely  shielded from any  disturbance  due to the
spray.
The nozzle and spray  shaping  device can be mounted on any type of robotic arm,
conveyor,  or X-Y table.  Patterns of virtually  any shape can be produced.  For
example,  discrete dots, containing only a few-tenths of a microliter of flux or
continuous patterns, such as lines, can be deposited.

MCS Infinity System

The Sono-Tek  MCS Infinity  System is a precise,  highly efficient spray coating
system designed for general  top-down  spraying  applications.  This new product
consists of (i) a control module which provides power to the ultrasonic  nozzle,
liquid  delivery,  and  electronic  control  and  interface  functions,  (ii) an
ultrasonic  nozzle,  and (iii) a vertical jet  assembly  which is available in a
wide variety of designs to  accommodate  various  spray  widths.  Each module is
capable of spraying areas as narrow as 0.25 inches or as wide as one foot. Areas
greater than one foot in width can be accommodated by grouping  together as many
individual modules as necessary. This versatile, modular system delivers a soft,
uniform and highly  controllable  spray over any substrate width. These standard
modules  are then custom  configured  for each  user's  application  with custom
hardware and interface electronics.

Liquid Delivery Systems

During  Fiscal 1998,  Sono-Tek  announced a family of liquid  delivery  systems.
These new  products  are  intended to enable  customers  to purchase a complete,
fully  integrated and tested spray solution from a single  supplier.  The liquid
delivery systems fall into four basic categories.

1.       Syringe Pumps are the most precise of all liquid delivery methods,  and
         are ideal for very low flow rates,  including  single shots down to the
         nanoliter (one-billionth of a liter) range.

2.       Gear Type Metering Pumps are characterized by their capability to meter
         the flow of liquid  accurately  over a wide range of flow rates without
         pulsation. Two models are available to accommodate various flow ranges.

3.       Pressurized  Reservoir  Systems  provide  a highly  reliable,  yet cost
         effective  approach  for  use  in  the  most  demanding   applications,
         especially  where the liquid  contains  undissolved  solids or abrasive
         materials.  Several  models are  available,  ranging from 6 ounces to 3
         gallon reservoir capacities, and can be used for either continuous flow
         or single-shot dispensing.

4.       Gravity  Operated  Systems are a low cost,  versatile  solution for use
         primarily in laboratory applications or for feasibility testing.

Manufacturing

The Company  currently  employs twelve people for its  manufacturing and quality
control activities.  The Company's  manufacturing  operations are located in one
facility in the town of Milton, New York. As the Company expands its business by
diversifying  its  product  line,  the  Company may need to expand into a larger
facility.

The Company's current  manufacturing area consists of (i) a machine shop, (ii) a
nozzle  assembly/test  area,  (iii) an electronics  assembly area, (iv) a system
assembly  area, and (v) a receiving and shipping area. The machine shop produces
machined  parts for nozzle  systems,  components  for  development  projects and
custom parts to satisfy unique customer requirements.  During the fourth quarter
of Fiscal 1998, the Company purchased new production equipment which has reduced
production costs and improved quality. It is believed that all of these services
could be obtained at numerous local machine shops if required.

The nozzle  assembly  and test area  assembles  the machined  components  of the
nozzle with purchased crystals and electrodes, and after a visual inspection and
aging period,  subjects the nozzle to test  procedures to assess its performance
characteristics.  In the electronics assembly area, assembled electronic circuit
boards,  pumps,  and power  supplies are mounted in sheet metal  enclosures  and
wired  to  provide   interconnections  between  the  individual  components  and
sub-assemblies.  The circuit  boards and the  components  that populate them, as
well as the sheet metal components, are purchased from outside suppliers and are
available from a wide range of suppliers throughout the world.

The system  assembly area combines the  assembled  modules from the  electronics
assembly area, the assembled and tested ultrasonic  nozzle, and additional sheet
metal and wiring to complete  SonoFlux  systems,  MCS Infinity  Systems,  Liquid
Delivery Systems, and MCS Accu Mist Systems.

All raw materials used in the Company's products are readily available from many
different domestic suppliers.

The Company  provides a limited  warranty on all of its products  covering parts
and labor for a period of one year from the date of sale.

The Company has begun to purchase for resale,  pressure  nozzles from a European
manufacturer  with whom the  Company  intends to enter  into a U.S.  distributor
agreement.  The Company began sales of the pressure nozzles manufactured by this
European manufacturer in Fiscal 1999.

The Company maintains  comprehensive  general  liability  insurance in an amount
which it believes is adequate for the nature of its operations.

The Company became ISO 9001  Registered in September 1998.  Management  believes
that achieving this standard demonstrates a long-term commitment to the business
and will provide a competitive edge in marketing. In addition to the high degree
of quality  implied  by being ISO  registered,  the  Company  expects  that such
registration  will  discipline  the  Company in running  its  business  and will
stimulate continuous improvement.

Patents

The  Company's  business  is based in part on the  technology  covered  by eight
United  States  patents held by the  Company,  two of which have expired with no
material effect on the Company. Patent applications,  based on the United States
applications,   covering  fundamental  aspects  of  the  ultrasonic   technology
developed by the Company have been issued in several foreign jurisdictions.  Two
patents have expired and the rest will expire between now and December 2007. The
Company's  earliest patent on its  central-bolt  nozzle design,  used in current
product  offerings,  is due to expire in  October  1999.  The  Company  has been
granted a patent on the spray  assembly  portion of its SonoFlux  System,  which
will expire in June, 2010. There can be no assurance that the Company's existing
patents will, if challenged, be upheld, or that any such patents will afford the
necessary  degree of patent  protection  with  respect  to the  nozzle  systems.
Furthermore,  due to the high cost of  maintaining  patents in  several  foreign
jurisdictions,  the Company  decided not to maintain  its patent  protection  in
certain  countries  in which the Company  believes the  protection  is no longer
required.  There can be no  assurance  that  events will not occur  which,  as a
result of the Company's failure to maintain its patent protection,  would have a
material adverse affect on the Company's sales in such foreign jurisdictions.

In  addition,  the Company may be unable,  for  financial or other  reasons,  to
enforce its rights  under its  patents.  The Company  also relies on  unpatented
know-how in the  production  of its nozzle  systems.  Management is aware of one
other company that has  developed a nozzle that operates in a manner  similar to
the nozzle that is part of the Company's nozzle systems. This company has access
to  financial  resources  significantly  greater  than the  Company's  financial
resources.  There  can be no  assurance  that  this  company  will  not  develop
additional  nozzle  designs and thus  expand the  applications  of its  nozzles.
Moreover,  technological  advances have evolved in the nozzle industry and there
can be no  assurance  that these  companies or other  entities  with far greater
resources  and   capabilities   than  the  Company  will  not  develop  products
competitive   with  or   superior  to  the   Company's   nozzle   system.   (See
"Competition").

Competition

Ultrasonic  nozzles  are sold  primarily  to  customers  that  require  specific
performance  characteristics which the Company believes are not attainable using
competing methods such as pressure nozzles or other coating methods. At present,
management  is aware of only one other  company that  manufactures  nozzles that
operate  in a manner  similar to the  Company's  ultrasonic  nozzle.  Management
believes this company  offers a very limited range of ultrasonic  products,  has
not introduced any new products in several years,  and is rarely  encountered by
the Company's sales force.  Management  believes this company does not currently
present any significant competition to the Company's products.

In the electronic  fabrication area, the Company's SonoFlux System competes with
spray fluxing  systems from several other  companies.  Sono-Tek was a pioneer in
this industry and has become one of the  industry's  leading  suppliers of spray
fluxing equipment. The Company has competed favorably against these companies in
the  past  based  on  the  ease-of-use,  performance,  and  reliability  of  its
equipment.  Management  believes  that  Sono-Tek  also has a  reputation  in the
industry of providing excellent customer support and service.

Although  management  believes  that  it has  competed  against  such  companies
successfully  in the past,  there can be no  assurance  that the Company will be
able to successfully compete against these Companies in the future.

The Company  believes that a large market exists for industrial spray nozzles in
the U.S.  Sono-Tek  competes  with  several well  established  companies in this
market.  Sono-Tek believes it will be able to compete  effectively against these
companies  because it will offer a complete  range of  interchangeable  products
that are competitively priced. The Company also believes that it will be able to
offer better customer  support and service,  be more flexible in offering custom
products to satisfy unique  customer  requirements,  be able to provide a better
level of  application  engineering  support,  and  provide  complete  "turn key"
solutions which many customers find desirable.

Employees

As of May 28, 1999, the Company had 28 full-time employees. The Company believes
that its relationship with its employees is good.


(d) Financial Information about Foreign and Domestic Operations and Export Sales

The Company has focused  primarily on the North American market.  In March 1998,
the Company entered into an agreement with a European nozzle manufacturer to see
its line of pressure  nozzles in the U.S. The Company also utilizes  independent
sales representatives or sales representative companies throughout North America
(including  parts  of  Canada  and  Mexico)  to  sell  SonoFlux  equipment  on a
commission  basis.  During  Fiscal  1999,  1998 and 1997,  the sales to  foreign
customers   accounted  for  approximately   $620,000,   $435,000  and  $679,000,
respectively, or 17%, 12% and 22%, respectively, of total revenues.

(e)      Backlog

The backlog for the Company's products was approximately $115,000,  $104,000 and
$81,000 as of  February  28,  1999,  1998 and 1997,  respectively.  The  Company
anticipates that it will ship all of its February 28, 1999 backlog during Fiscal
2000.

ITEM 2            Properties

The  Company's  offices,   product   development,   manufacturing  and  assembly
facilities are located in one building consisting of 13,200 square feet of space
at 2012 Route 9W,  Building  3,  Milton,  New York.  The  Company  leased  these
facilities  pursuant to a lease which expired  January 31, 1997. The Company had
an option at the end of the lease term to renew the lease for an additional five
year period,  but that option was not exercised.  As of May 28, 1999 the Company
has not signed a renewal lease  agreement.  The Company is making  payments on a
month-to-month basis equal to the amount that would have been required per month
if the option had been exercised.

As the Company increases its sales of new products, and plans the acquisition of
another  manufacturing  firm (see "General  Development of Business" above), the
Company may need to expand into a larger facility or to rent or lease additional
space.

ITEM 3   Legal Proceedings

None

ITEM 4            Submission of Matters to a Vote of Security Holders
- ------

None

                                     PART II

ITEM 5     Market for Registrant's Common Equity and Related Stockholder Matters
- ------

(a) The Company's Common Stock trades in the over-the-counter  market on the OTC
Bulletin Board. The following table sets forth the range of high and low closing
quotations for the Company's Common Stock for the periods indicated as furnished
by the National Quotations Bureau, Incorporated.
<TABLE>
<CAPTION>
FISCAL YEAR ENDED                      FEBRUARY 28,                             FEBRUARY 28,
                                            1999                                     1998
                                            ----                                     ----
                                    HIGH             LOW                   HIGH               LOW
                                    ----             ---                   ----               ---
<S>                                 <C>              <C>                   <C>                <C>
First Quarter                       $ 7/8            $ 1/2                 $ 3/8              $ 9/32
Second Quarter                       41/64             7/16                  7/16              17/64
Third Quarter                        15/32             7/32                    1                5/16
Fourth Quarter                        3/8              1/8                  13/16               1/2
</TABLE>

The above quotations are believed to represent  inter-dealer  quotations without
retail  markups,   markdowns  or  commissions  and  may  not  represent   actual
transactions. The Company believes that, although limited or sporadic quotations
exist,  there is no established  public trading market for the Company's  Common
Stock.

(b) As of May 28,  1999  there were 295  record  holders  of the  Company's
Common Stock.

(c) The Company has not paid any cash  dividends  on its Common  Stock since its
inception and intends to retain earnings, if any, for use in its business or for
other corporate purposes.

ITEM 6   Selected Financial Data(1)
<TABLE>
<CAPTION>
Year Ended                    02/28/99          02/28/98         02/28/97          02/29/96           02/28/95
- ----------                    --------          --------         --------          --------           --------
<S>                           <C>               <C>              <C>               <C>                <C>
Net Sales                     $2,902,951        $3,570,379       $3,110,672        $2,747,891         $2,548,363
                              ==========        ==========       ==========        ==========         ==========

Net (Loss)Income              $ (810,702) (2)   $  252,047       $  152,639        $  155,078         $ (483,050)
                              ===========       ==========       ==========        ==========         ==========

Basic (Loss) Earnings
    Per Share                   $(0.18)           $0.06            $0.04             $0.04              $(0.12)
                                ======            =====            =====             =====              ======

Diluted (Loss) Earnings
    Per Share                   $(0.18)           $0.05            $0.03             $0.04              $(0.12)
                                ======            =====            =====             =====              ======

Cash Dividends                    None             None              None             None                None

Weighted Average
    Shares - Basic             4,386,799         4,376,064        4,204,913         4,204,913          3,873,146
                               =========         =========        =========         =========          =========

Weighted Average
    Shares - Diluted(3)        4,386,799         4,773,667        4,507,441         4,477,646          3,911,323
                               =========         =========        =========         =========          =========

Total Assets                  $1,335,649        $1,728,678       $1,251,868        $1,199,717         $1,211,161
                              ==========        ==========       ==========        ==========         ==========

Long-Term Liabilities         $   46,376(4)     $  585,898       $  576,722        $  668,082         $  775,816
                              ==========        ==========       ==========        ==========         ==========
<FN>
(1) Should be read in conjunction with the Financial Statements and notes thereto.
(2) Upon conversion of $530,000  Subordinated Debt to equity, the Company expensed
$354,280 of which $302,857 is due to the lowering of the  conversion  price from
$.70 to $.30 and  $51,423  is due to the value of the new  warrants  granted.
(3) Stock options for  employees and outside  consultants  are antidilutive during
Fiscal 1999 as a result of the net loss and therefore are not  considered in the
Diluted EPS calculation.
(4) The Long-Term  Liabilities  decreased in Fiscal 1999 due to the  conversion of
the  Subordinated  Convertible  Debt of  $530,000  to equity.
</FN>
</TABLE>

ITEM  7  Management's Discussion and Analysis of Financial Condition and Results
 of Operations

Forward-Looking Statements

Certain   statements  made  in  this  report  may  constitute   "forward-looking
statements"   within  the  meaning  of  the  Federal   Securities   Laws.   Such
forward-looking  statements include statements  regarding the intent,  belief or
current  expectations  of the Company and its  management  and involve known and
unknown  risks,  uncertainties  and other  factors  which  may cause the  actual
results,  performance or achievements of the Company to be materially  different
from any future  results,  performance or  achievements  expressed or implied by
such forward-looking  statements.  Such factors include, among other things, the
following:  general  economic and business  conditions;  political,  regulatory,
competitive and technological developments affecting the Company's operations or
the demand for its products;  timely  development  and market  acceptance of new
products;  adequacy of  financing;  capacity  additions;  and ability to enforce
patents.
The Company  undertakes  no obligation  to update  publicly any  forward-looking
statement.

Capital Resources and Liquidity

On  February  28,  1999  the  Company  had  working   capital  of  $272,916  and
stockholders'  equity of $398,682.  This compares to working capital of $691,335
and  stockholders'  equity of $278,557 on February 28, 1998. The net decrease in
working  capital of $418,419  is due to a decrease in cash and cash  equivalents
and accounts receivable,  partially offset by an increase in inventory.  The net
increase  of  $120,125  in the  Company's  stockholders'  equity  is a result of
converting  $530,000 of Convertible  Secured  Subordinated  Promissory  Notes to
equity, net of the 1999 operating loss.

During Fiscal 1999 and 1998 the Company  reduced its  obligations on a bank loan
by  $46,253  and  $94,173,  respectively.  The loan was paid off in full  during
Fiscal 1999.  During Fiscal 1998 the Company obtained a $150,000  revolving line
of credit which was increased in Fiscal 1999 to $300,000.  The line of credit is
collateralized by accounts receivable, inventory and all other personal property
of the Company,  and  guaranteed by the CEO of the Company.  As of May 28, 1999,
the Company has used $250,948 from the line of credit.

Capital expenditures decreased during Fiscal 1999 to $44,000 from $95,000 during
Fiscal 1998. The decrease was mainly due to the fact that the Company  purchased
a large piece of production equipment during Fiscal 1998. During Fiscal 1998 the
Company  entered into a  collateralized  $57,000 term loan agreement to purchase
new production  equipment.  During Fiscal 1999, $9,204 was paid on the equipment
loan.

The  Company's  Convertible  Secured  Subordinated  Promissory  Notes  that were
scheduled  to mature on August 15,  2000 were  converted  under the Fourth  Note
Amendment  Agreement  dated February 26, 1999.  This agreement  provided for the
reduction  in the  conversion  price from $.65 per share to $.30 per share.  The
Noteholders  received stock for the converted  Notes and for the unpaid interest
as of February 26, 1999.  At the same time,  the exercise  price of the warrants
was reduced from $1.50 per share to $.65 per share,  and the expiration  date of
the warrants was extended to February 28, 2002.

Due to the losses  incurred  during  Fiscal  1999,  the Company was  required to
borrow on a short term basis from two  officers  of the  Company.  As of May 28,
1999, the balance owed the officers was $165,000.  These losses also limited the
Company's  ability to pay trade  creditors in a timely  manner and make interest
payments on the Convertible Secured Subordinated Promissory Notes.

As necessary, the Company plans on funding the operations by using the available
borrowings  under the current line of credit  agreement and obtaining loans from
shareholders (as required in the past).

Although there can be no assurances,  management  believes that the introduction
of the MCS Accu Mist,  MCS Infinity, and Liquid Delivery Systems, the additional
sales channels for ultrasonic  nozzles,  and the sustained sales of the SonoFlux
9500 will lead to broader markets and increases in sales and profits, which will
in turn allow the Company to meet its current obligations as they become due.

Results of Operations - 1999 Compared to 1998

The Company's sales decreased $667,428 or 19% from $3,570,379 for Fiscal 1998 to
$2,902,951  for Fiscal 1999. The decrease in sales was a result of a decrease in
unit sales of the Company's  SonoFlux  Systems and  ultrasonic  nozzles,  partly
offset by an increase in new product sales.  Sales of fluxing systems  decreased
by $632,995 or 24% from  $2,692,923 in Fiscal 1998 to $2,059,928 in Fiscal 1999.
The Company  attributes  the  decrease in sales of this product to the excess of
supply over demand in the  electronics  assembly  industry  for the last several
months.  Sales of the Company's  nozzle systems  decreased  $233,113 or 31% from
$760,197 in Fiscal 1998 to $527,084 in Fiscal 1999.  This  decrease was a result
of lower  sales and a  decrease  in nozzle  repairs.  During  Fiscal  1999,  new
products accounted for $309,594 in sales or 10% of total sales.

The Company's  cost of goods sold  decreased  $123,600 or 7% from  $1,740,217 in
Fiscal 1998 to $1,616,617 in Fiscal 1999.  The decrease in cost of goods sold is
a result of the decrease in sales of the Company's products,  and the subsequent
decrease in material costs partially offset by an increase in cost of goods sold
related to new products.  The gross profit margin decreased $543,828 or 30% from
$1,830,162 in Fiscal 1998 to $1,286,334 in Fiscal 1999.  The gross profit margin
was 44% and 51% of sales for Fiscal 1999 and 1998, respectively. The decrease is
attributable  to  the  increases  in  personnel  and  benefit  costs,  including
temporary employees,  additional  depreciation on production equipment purchased
at the end of  Fiscal  1998,  and also to  supplies  needed to  operate  the new
production equipment.

Research and product development costs increased $78,066 or 19% from $409,722 in
Fiscal 1998 to $487,788 in Fiscal 1999.  The increase is a result of  additional
staff to work on new product development.

General and  administrative  costs  increased  $102,563 or 26% from  $395,954 in
Fiscal 1998 to $498,517 in Fiscal 1999.  The increase was a result of consulting
expenses related to the planned acquisition and raising the capital necessary to
consummate the transaction,  a settlement to a former  employee,  and additional
employee and benefit costs. In Fiscal 1999, the Company also recorded a non-cash
charge of  $354,280  associated  with  inducing  Noteholders  to  convert  their
Convertible Secured Subordinated Promissory Notes.

Sales and marketing expense decreased $16,704 or 2% from $723,919 in Fiscal 1998
to $707,215 in Fiscal 1999. A decrease in commissions  of $55,000,  due to lower
sales,  was offset by  approximately  $72,000 in startup costs  associated  with
expenses incurred in the distribution of pressure nozzles.

The Company's  operating  profit  decreased  $1,062,033 or 353% from $300,567 in
Fiscal 1998 to a loss of  $761,466 in Fiscal  1999.  The  decrease in  operating
profit  is mainly a result  of  decreased  sales of the  Company's  products,  a
non-cash  charge  associated  with the  conversion  of the  Convertible  Secured
Subordinated  Promissory Notes of $354,280 and the additional expense of $72,000
related to start up activities associated with the sales of pressure nozzles.

Interest and other income increased  $10,844 from $368 in Fiscal 1998 to $11,212
in Fiscal 1999. The Company  enrolled in a  reinvestment  program with its bank,
providing interest income on unused cash for a total of $3,000. The Company also
recovered  unclaimed  customer  credits of $8,000.  Interest  expense  increased
$11,560  or 24% from  $48,888 in Fiscal  1998 to  $60,448 in Fiscal  1999 due to
interest  incurred  on a  collateralized  equipment  term loan  entered  into in
February 1998, and additional balances on the line of credit.

Inflation  and changing  prices did not have a material  effect on the Company's
operations in Fiscal 1998 or 1999.

Results of Operations - 1998 Compared to 1997

The Company's sales increased $459,707 or 15% from $3,110,672 for Fiscal 1997 to
$3,570,379  for Fiscal 1998.  The increase in sales resulted from an increase in
unit sales of the Company's  SonoFlux Systems  partially offset by a decrease in
sales of the Company's  nozzle systems.  Sales of the SonoFlux System  increased
$630,610 or 31% from $2,062,313 in Fiscal 1997 to $2,692,923 in Fiscal 1998. The
Company  attributes  the increase in sales of this product to the success of its
newest generation of SonoFlux Systems the "9500".  Sales of the Company's nozzle
systems decreased  $288,160 or 27% from $1,048,357 in Fiscal 1997 to $760,197 in
Fiscal 1998 due to a decrease in nozzle repairs.

The Company's  cost of goods sold increased  $221,244 or 15% from  $1,518,971 in
Fiscal 1997 to $1,740,217 in Fiscal 1998.  The increase in cost of goods sold is
a result of an increase in sales of the Company's products,  a change in product
mix and an increase in the cost of certain purchased  components of the SonoFlux
System. The gross profit margin remained constant between Fiscal 1997 and 1998.

Research and product development costs increased $40,590 or 11% from $369,133 in
Fiscal 1997 to $409,722 in Fiscal 1998.  The increase is a result of  additional
staff to work on new product development.

General and  administrative  expense  increased  $18,920 or 5% from  $377,037 in
Fiscal 1997 to $395,954 in Fiscal 1998 as a result of additional  employee costs
and professional fees.

Sales and marketing  expense  increased  $93,625 or $15% from $630,295 in Fiscal
1997 to $723,919 in Fiscal 1998. The increase was due to  commissions  generated
from higher sales.

The Company's  operating profit increased $85,331 or 40% from $215,236 in Fiscal
1997 to $300,567 in Fiscal 1998. The increase in operating profit is a result of
increased  sales of the Company's  products while keeping  increases in overhead
expenses to a minimum.

Interest and other income  decreased $3,823 or 91% from $4,192 in Fiscal 1997 to
$369 in Fiscal 1998.  Interest expense  decreased $17,901 or 27% from $66,789 in
Fiscal  1997 to  $48,888  in Fiscal  1998 due to  monthly  installment  payments
reducing the outstanding  principal balances  outstanding during Fiscal 1998 New
equipment  that was  purchased  during the 4th  quarter was  financed  and had a
negligible effect on Fiscal 1998 interest expense.

Inflation  and changing  prices did not have a material  effect on the Company's
operations in Fiscal 1998 or 1997.

Year 2000 Compliance

The Company has  performed a thorough  assessment to determine its readiness for
the Year  2000  (Y2K).  This  assessment  identified  areas  that  needed  to be
modified,  and resulted in the Company upgrading both hardware and software used
internally.

As part of its  assessment,  the  Company  evaluated  its  phone,  security  and
manufacturing  machinery  and  determined  that  all of  these  systems  are Y2K
compliant.  The Company has also evaluated the software and hardware used in its
products and determined  that they are Y2K  compliant.  The Company has surveyed
its major  suppliers for their Y2K readiness.  Because all major  components and
materials  used by the Company in the  manufacture  of its  products are readily
available  from  several  suppliers,  management  considers  this  area to be of
minimal risk.

At the present time, a contingency plan has not been developed. The Company will
continue to monitor the need for a  contingency  plan.  The Company has incurred
internal staff costs, as well as the expense to purchase additional hardware and
software of  approximately  $25,000.  The  additional  costs  related to the Y2K
compliance is  approximately  $10,000 and is not  anticipated to have a material
effect on the Company's business,  results of operations or financial condition.
Despite its efforts to survey its  customers,  suppliers and service  providers,
the  Company  cannot be certain as to the actual Y2K  readiness  of these  third
parties  or the  impact  that any  non-compliance  on their part may have on the
Company's business, results of operations or financial condition. This is a Year
2000  readiness  disclosure  entitled to protection as provided in the Year 2000
Information and Readiness Disclosure Act.

ITEM 7A           Quantitative and Qualitative Disclosures about Market Risk

The Company is exposed to market risk related to changes in interest  rates and,
to a lesser extent foreign  currency  exchange  rates.  The interest rate on the
Company's debt is based on  fluctuations  in the prime rates.  If the prime rate
increased by 1 percentage point from the levels at February 28, 1999, the effect
on the Company's results of operations would approximate $3,000.

ITEM 8   Financial Statements and Supplementary Data

Financial  information  required by Item 8 is included elsewhere in this report.
(See Part IV, Item 14.)

ITEM 9 Changes in and Disagreements with Accountants on Accounting and Financial
Disclosure

Not applicable

                                    PART III

ITEM 10  Directors and Executive Officers of the Registrant

         (a)      Identification of Directors
<TABLE>
<CAPTION>
         Name                       Age     Position with the Company
         ----                       ---     -------------------------
         <S>                        <C>     <C>
         John J. Antretter          36      Director
         Harvey L. Berger           60      President and a Director
         Christopher L. Coccio      57      Director
         James L. Kehoe             52      Chairman, Chief Executive Officer and a Director
         Samuel Schwartz            79      Director
         J. Duncan Urquhart         45      Director
</TABLE>

Mr. Antretter has been a Director of the Company since February 1999. Dr. Berger
has been a  Director  of the  Company  since June  1975.  Mr.  Coccio has been a
Director of the Company  since June 1998.  Mr.  Kehoe has been a Director  since
June 1991. Mr.  Schwartz has been a Director since August 1987. Mr. Urquhart has
been a Director since September 1988.

The Board of Directors is divided into two classes,  which were  established  by
the Company's shareholders at their annual meeting held on October 19, 1989. The
directors  in  each  class  serve  for a term  of two  years,  and  until  their
respective  successors are duly elected and qualified.  The terms of the classes
are  staggered  so that only one class of  directors  is elected at each  annual
meeting of the Company. The terms of Messrs.  Kehoe,  Schwartz and Urquhart will
be until the annual  meeting to be held in 2000,  and the term of Dr. Berger and
Messrs.  Antretter  and Coccio  will be until the  annual  meeting to be held in
1999,  and in each case  until  their  respective  successors  are  elected  and
qualified.

(b)      Identification of Executive Officers
<TABLE>
<CAPTION>
         Name                        Age    Position with the Company
         ----                        ---    -------------------------
         <S>                         <C>    <C>
         Harvey L. Berger            60     President and a Director
         James L. Kehoe              52     Chairman, Chief Executive Officer and a Director
         Kathleen N. Martin          46     Chief Financial Officer and Treasurer
         William J. McCormick        42     Vice President
</TABLE>

Dr. Berger was Vice Chairman of the Board from March 1981 to September  1985. He
was President from November 1981 to September 1984 and again became President in
September  1985.  From  September  1986 to  September  1988 he  also  served  as
Treasurer.  Mr. Kehoe has served as Chairman since May 1999 and Chief  Executive
Officer since August 1993. Ms. Martin has served as Chief Financial  Officer and
Treasurer since November 1997. Mr.  McCormick has served as Vice President since
May 1999.

The  foregoing  officers  are  elected  for  terms of one  year or  until  their
successors  are duly elected and qualified or until  terminated by the action of
the Board of Directors.  There are no arrangements or understandings between any
executive officer and any other persons(s)  pursuant to which he was or is to be
selected as an officer.

(c)      Identification of Certain Significant Employees

         Not applicable.

(d)      Family Relationships

         None.

(e)      Business Experience

JOHN J.  ANTRETTER has been a consultant to the Company since November 1998, and
a Director since February 1999.  From January 1996 through  September  1998, Mr.
Antretter was Chairman and CEO of Technology  Manufacturing & Design Inc. (TMD),
an Austin, TX based contract  electronics  manufacturing  firm. Prior to joining
TMD, he was the CEO and a Director of Plasmaco,  Inc., a developer of flat panel
display systems from 1994 to 1996. In January 1996, Mr. Antretter negotiated the
sale of Plasmaco to Panasonic.  Mr.  Antretter has additional  experience in the
venture  capital and investment  banking  fields,  and was a commercial  lending
officer for the Bank of New York.  Mr.  Antretter  received his MBA from Fordham
University in 1989.

DR.  HARVEY L. BERGER has been a Director of the Company since June 1975. He was
President of the Company from  November  1981 to September  1984,  and has again
been  President of the Company since  September  1985.  From  September  1986 to
September 1988 he also served as Treasurer.  He was Vice Chairman of the Company
from March 1981 to September  1985.  Dr.  Berger  holds a Ph.D.  in physics from
Rensselaer  Polytechnic Institute and is a member of the Marist College Advisory
Board.

CHRISTOPHER  L. COCCIO has been a Director of the Company since June 1998.  From
1964 to 1996 he held various  management  positions at General Electric Company.
He received a B.S.  from  Stevens  Institute  of  Technology,  an M.S.  from the
University of Colorado, and a Ph.D. from Rensselaer Polytechnic Institute. He is
a  consultant  to the New York  State  Legislative  Commission  on  Science  and
Technology.

JAMES L. KEHOE has been  Chairman of the Board  since May 1999,  Director of the
Company since June, 1991 and Chief Executive Officer of the Company since August
1993.  Prior to that, he was President and Chief Executive  Officer of Plasmaco,
Inc.,  which he founded in 1987 and  remained as  President  and CEO until 1993.
Plasmaco is involved in the  development and manufacture of AC plasma flat panel
displays.  Prior to founding  Plasmaco,  Mr.  Kehoe was  employed for twenty two
years by International  Business Machines Corporation where he held a variety of
engineering and management positions.

KATHLEEN N. MARTIN has been the Chief  Financial  Officer and  Treasurer  of the
Company  since  November  1997.  From 1992 to 1997,  Ms.  Martin was employed by
Plasmaco, Inc. where she served as Accounting Analyst and Controller. Ms. Martin
has a B.A. in Mathematics  from Hartwick  College and a B.S. in Accounting  from
the State University of New York at New Paltz.

WILLIAM J. MC CORMICK has been Vice  President of the Company since May 1999. He
joined  Sono-Tek in 1994 as a sales  engineer.  Since April 1995 he has been the
Engineering  Manager of the Company.  Prior to joining  Sono-Tek,  Mr. McCormick
worked  for 13 years at IBM and  Highland  Manufacturing  Company  where he held
various technical,  sales, and management positions.  He has over thirteen years
of  experience   managing  various  business   functions  such  as  engineering,
manufacturing, operations, sales, and finance. He has an Electronics Engineering
Technology  Degree from Ohio  Institute of  Technology,  and is pursuing his MBA
from SUNY at New Paltz.

SAMUEL  SCHWARTZ  has been a Director of the Company  since  August 1987 and was
Chairman of the Board from February  1993 to May 1999.  From 1959 to 1992 he was
the  Chairman  and CEO of  Krystinel  Corporation,  a  manufacturer  of  ceramic
magnetic  components used in electronic  circuitry.  He received a B.CH.E.  from
Rensselaer  Polytechnic Institute in 1941 and a M.CH.E. from New York University
in 1948.

J. DUNCAN  URQUHART  has been a Director of the Company  since  September  1988.
Since January 1999 he has been a Consultant Associate with Resources Connection,
which provides contract accounting services. From October 1997 to December 1998,
Mr. Urquhart was Director of Business  Operations at The Gun Parts  Corporation,
an international  supplier of gun parts.  Prior to his resignation from Sono-Tek
in October  1997,  he was  Controller  of the Company  from  January  1988,  and
Treasurer of the Company from September 1988.

Section 16(a) Beneficial Ownership Reporting Compliance

Samuel  Schwartz,  a Director  and  beneficial  owner of greater than 10% of the
outstanding  common  stock of the  Company,  did not  timely  file a Form 4 with
respect to certain  shares of stock he acquired upon  conversion of  outstanding
debt.  Kathleen N. Martin,  Chief Financial Officer and Treasurer did not timely
file a Form 5 with respect to certain options granted by the Board of Directors.

ITEM 11  Executive Compensation

The following table sets forth the aggregate remuneration paid or accrued by the
Company  through  February  28,  1999 for the  Chief  Executive  Officer  of the
Company. No other executive officer received aggregate remuneration that equaled
or exceeded $100,000 for the fiscal year ended February 28, 1999.
<TABLE>

                           SUMMARY COMPENSATION TABLE
<CAPTION>
                                                                             Long Term
                                         Annual Compensation               Compensation
Name and                                                                 Awards, Securities              All Other
Principal Position         Year       Salary ($)     Bonus ($)         Underlying Options (#)       Compensation ($)1
- ---------------------------------------------------------------------------------------------------------------------
<S>                        <C>         <C>              <C>                    <C>                       <C>
James L. Kehoe             1999        $115,000         $0                           0                   $2,300
Chief Executive Officer    1998         102,000          0                     200,000                    1,244
                           1997          85,000          0                           0                      818
</TABLE>

1 Dollar amounts are Company contributions under the SARSEP.

The following table sets forth information regarding option exercises during the
fiscal year ended February 28, 1999, as well as any unexercised  options held as
of February 28, 1999 by each named executive.
<TABLE>
<CAPTION>
                                                           Number of Securities Underlying   Value of Unexercised
                                                                 Unexercised Options         In the Money Options
                                   Shares                        at Fiscal Year End (#)      At Fiscal Year End ($)
                                Acquire on       Value
Name                            Exercise (#)   Realized ($)   Exercisable Unexercisable   Exercisable  Unexercisable
- --------------------------------------------------------------------------------------------------------------------
<S>                                   <C>          <C>          <C>           <C>              <C>         <C>
Harvey L. Berger                      0            0             50,000            0           0           0
James L. Kehoe                        0            0            270,000            0           0           0
Kathleen N. Martin                    0            0              9,000       41,000           0           0
William J. McCormick                  0            0             20,000       30,000           0           0
</TABLE>

Compensation Committee Interlocks and Insider Participation

The  Company's  Board of  Directors  has a  Compensation  Committee  composed of
Christopher L. Coccio, Samuel Schwartz and J. Duncan Urquhart,  all Directors of
the Company.  However,  the Compensation  Committee serves an advisory  function
only.  All  decisions  regarding  compensation  are  made by the  full  Board of
Directors, including Mr. Berger and Mr. Kehoe who could participate in decisions
regarding the compensation of the Company's executive officers,  including their
own.

ITEM 12  Security Ownership of Certain Beneficial Owners and Management

The following information is furnished as of May 28, 1999 to indicate beneficial
ownership of the  Company's  Common Stock by each  Director,  by each  executive
officer,  by all Directors and executive  officers as a group and by each person
known to the Company to be the beneficial owner of more than 5% of the Company's
outstanding  Common Stock. Such information has been furnished to the Company by
the indicated  owners.  Unless  otherwise  indicated,  the named person has sole
voting and investment power.
<TABLE>
<CAPTION>

Name (and address if                      Amount
   more than 5%) of                    Beneficially
   Beneficial owner                       Owned               Percent
   ----------------                       -----               -------

Directors
<S>                                  <C>                      <C>
     *John J. Antretter                 20,000(1)               **
     *Harvey L. Berger                 371,700(2)              4.8%
     *Christopher L. Coccio             15,000                  **
     *James L. Kehoe                   603,400(3)              7.8%
     *Samuel Schwartz                  786,609(4)             10.1%
     *J. Duncan Urquhart                10,000(5)               **

Executive Officer
     *Kathleen N. Martin                14,000(6)               **
     *William J. McCormick              25,000(7)               **

All Executive Officers and
      Directors as a Group           1,845,709(8)             23.8%

Additional 5% owners

     Herbert Spiegel                   514,692(9)              6.6%
     425 East 58th Street
     New York, NY 10022


*c/o Sono-Tek Corporation, 2012 Route 9W, Bldg. 3, Milton, NY  12547.

** Less than 1%
<FN>

(1)  Includes options to purchase 20,000 shares under the 1993 Plan.

(2)  Includes 4,000 shares in the name of Dr. Berger's wife and includes options
to purchase 50,000 shares under the 1993 Plan.

(3)  Includes options to purchase 270,000 shares under the 1993 Plan, plus
warrants to purchase 300,000 shares awarded by the Board of Directors in May 1999.

(4)  Includes 166,667 shares issued for the conversion of a convertible  secured
subordinated  promissory  note in the principle sum of $50,000 and 12,888 shares
issued for accrued  interest  of $3,866  related to the note.  Also  assumes the
exercise  of a  warrant  Mr.  Schwartz  received  upon  conversion  of a secured
subordinated promissory note, which warrant is exercisable at $.65 per share for
an additional  71,400 shares of Common Stock. Also includes warrants to purchase
300,000 shares awarded by the Board of Directors in May 1999.

(5)  Includes options to purchase 10,000 shares granted in May 1999 under the 1993
Plan.

(6)  Includes options to purchase 9,000 shares under the 1993 Plan.

(7)  Includes options to purchase 20,000 shares under the 1993 Plan.

(8)  Includes options to purchase 309,000 shares under the 1993 Plan, and 179,555
shares from the  conversion of debt and interest and 71,400 shares from warrants
in footnote 4 above,  and  warrants to purchase  600,000  shares  awarded by the
Board of Directors in May 1999.

(9)  Includes 216,667 shares issued for the conversion of a convertible  secured
subordinated  promissory  note in the principle sum of $65,000 and 16,754 shares
issued for accrued  interest  of $5,026  related to the note.  Also  assumes the
exercise  of a  warrant  Mr.  Spiegel  received  upon  conversion  of a  secured
subordinated promissory note, which warrant is exercisable at $.65 per share for
an additional 92,820 shares of Common Stock.
</FN>
</TABLE>

ITEM. 13 Certain Relationships and Related Transactions

On  February  26,  1999 the  Directors  of the  Company  agreed  to  reduce  the
conversion price of the Convertible Secured  Subordinated  Promissory Notes from
$0.70 per common  share to $0.30 per common  share.  In addition to changing the
conversion  price of the Notes,  the  Directors  also  extended  the term of the
Warrants from August 15, 2000 to February 28, 2002,  adjusted the exercise price
from $1.50 per share to $0.65 per share,  provided that if the Company's  common
stock  trades  at a price  greater  than  $1.95 per share for a period of thirty
consecutive  trading  days,  the Company can force the  exercise of the Warrants
within ninety days of providing  notice to the holder,  and obtained a waiver of
all events and prospective events of default.  Samuel Schwartz agreed to convert
$50,000 in principal and $3,866 in interest into 179,555 shares of common stock,
and  Herbert  Spiegel  agreed to  convert  $65,000  in  principal  and $5,026 in
interest into 233,421 shares of common stock. As a result of the conversion, the
Company  recorded a non-cash  charge of $302,857  due to the lowered  conversion
price, and a non-cash charge of $51,423 due to the lowered warrant price.

During Fiscal 1999 Samuel Schwartz and James L. Kehoe loaned the Company a total
of $88,000 that was not repaid at February 28, 1999. The demand loans carried an
interest rate of prime plus 2% (9.75% at February 28, 1999).  Subsequent to year
end, Messrs.  Schwartz and Kehoe loaned an additional $77,000 to the Company. In
May 1999,  the Board of  Directors  awarded  each of them  warrants  to purchase
300,000 shares of the Company's common stock.

                                  PART IV

ITEM 14  Exhibits, Financial Statement Schedules, and Reports on Form 8-K

(a)(1) The financial  statements and schedules listed in the accompanying "Index
to Financial Statements" are filed as a part of this annual report.

(2) See (a)(1) above.

(3) Exhibits

Ex. No.  Description
3(a)4    Certificate of Incorporation of the Company and all amendments thereto.
3(b)1    By-laws of the Company as amended.
4(a)4    Form of Convertible Note.
4(b)3    Form of Warrant.
4(c)3    Master Security Agreement.
4(d)     The Company agrees to furnish a copy of the equipment loan referred to
         in the Company's financial statements to the Commission upon request.
4(e)6    Form of 1995 Amendment to Convertible Note.
4(f)7    Form of 1996 Amendment to Convertible Note.
4(g)9    Form of 1997 Amendment to Convertible Note
4(h)8    Letter agreement between the Company and The Bank of New York.
4(i)     Form of 1999 Amendment to Convertible Note.
4(j)     Mr. Kehoe's Personal Guarantee for the Bank of New York.
*10(a)4  Employment Agreement dated October 14, 1993 between the Company and Dr.
         Harvey L. Berger.
10(b)2   Lease for the Company's facilities in Milton, NY dated July 19, 1991.
10(c)2   Amendment No. 1 to Milton, NY lease dated December 27, 1991.
10(d)4   Amendment No. 2 to Milton, NY lease dated January 22, 1992.
*10(e)5  1993 Stock Incentive Plan as amended.
10(f)    Bank of New York Line of Credit.
23(a)    Independent Auditors' Consent.
27.1     Financial Data Schedule. EDGAR filing only.

* Management Contract or Compensatory Plan.

1        Incorporated herein by reference to exhibit 2 to Amendment No. 1 to
         Form 8-A, SEC file #0-16035.

2        Incorporated  herein by  reference to the  Company's  Form 10-K for the
         year ended February 29, 1992.

3        Incorporated herein by reference to the Company's Form 10-Q Quarterly
         Report for the quarter ended November 30, 1993.

4        Incorporated  herein by  reference to the  Company's  Form 10-K for the
         year ended February 28, 1994.

5        Incorporated herein by reference to the Company's Form 10-Q quarterly
         report for the quarter ended August 31, 1994.

6        Incorporated  herein by  reference to the  Company's  Form 10-K for the
         year ended February 28, 1995.

7        Incorporated  herein by  reference to the  Company's  Form 10-K for the
         year ended February 29, 1996.

8        Incorporated  herein by reference to the Company's  Form 10-Q quarterly
         report for the quarter ended May 31, 1996.

9        Incorporated  herein by  reference to the  Company's  Form 10-K for the
         year ended February 28, 1997.

(b)      Reports on Form 8-K.
         No reports on Form 8-K were filed during the last quarter of the period
covered by this report.


<PAGE>
                              SONO-TEK CORPORATION

                                    FORM 10-K

                                ITEMS 8 AND 14(d)

                   INDEX TO FINANCIAL STATEMENTS AND SCHEDULES

                      FOR THE YEAR ENDED FEBRUARY 28, 1999



INDEPENDENT AUDITORS' REPORT

FINANCIAL STATEMENTS (ITEM 8):

              Balance Sheets at February 28, 1999 and February 28, 1998

              Statements of Operations
                 For the Years Ended February 28, 1999, 1998 and 1997

              Statements of Stockholders' Equity (Deficiency)
                 For the Years Ended February 28, 1999, 1998 and 1997

              Statements of Cash Flows
                 For the Years Ended February 28, 1999, 1998 and 1997

              Notes to the Financial Statements



FINANCIAL STATEMENTS SCHEDULE (ITEM 14(d) SCHEDULE INCLUDED):

              Schedule II - Valuation and Qualifying Accounts

              All other  schedules  have been  omitted  because  the  conditions
requiring their filing do not exist or because the required information is given
in the financial statements, including the notes.
<PAGE>
INDEPENDENT AUDITOR'S REPORT

To the Stockholders and Directors of
Sono-Tek Corporation
Milton, New York

We have audited the  accompanying  balance sheets of Sono-Tek  Corporation  (the
"Company")  as of  February  28,  1999 and 1998 and the  related  statements  of
operations,  stockholders' equity  (deficiency),  and cash flows for each of the
three years in the period ended  February 28, 1999. Our audits also included the
financial  statement  schedule  listed in the index at item 14d. These financial
statements  and  financial  statement  schedule  are the  responsibility  of the
Company's  management.  Our  responsibility  is to  express  an opinion on these
financial  statements and financial  statement  schedule based on our audits. We
conducted our audits in accordance with generally  accepted auditing  standards.
Those standards  require that we plan and perform the audit to obtain reasonable
assurance   about  whether  the  financial   statements  are  free  of  material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits  provide a reasonable  basis for our opinion.  In our
opinion, such financial statements present fairly, in all material respects, the
financial  position  of the  Company as of  February  28,  1999 and 1998 and the
results of its  operations and its cash flows for each of the three years in the
period ended February 28, 1999 in conformity with generally accepted  accounting
principles.  Also  in our  opinion,  such  financial  statement  schedule,  when
considered  in  relation  to the basic  financial  statements  taken as a whole,
presents fairly in all material respects, the information set forth therein.



Deloitte & Touche LLP
Stamford, CT
May 5, 1999 (May 13, 1999 as to Note 16)
<PAGE>
<TABLE>
                              SONO-TEK CORPORATION
                                 BALANCE SHEETS

                                     ASSETS
                                                                                   February 28,
                                                                        -------------------------------
                                                                            1999                 1998
                                                                            ----                 ----
<S>                                                                     <C>                  <C>
Current Assets
     Cash and cash equivalents                                             $70,051             $113,759
     Accounts receivable (less allowance of $6,000 and $1,000
         in 1999 and 1998, respectively)                                   264,217              810,560
     Inventories - (Note 3)                                                787,200              615,459
     Prepaid expenses and other current assets                              42,039               15,780
                                                                         ---------            ---------
                  Total current assets                                   1,163,507            1,555,558

Equipment and furnishings (less accumulated depreciation and
     amortization of $407,486 and $369,398 in 1999 and 1998,
     respectively) (Note 4)                                                127,892              122,016

Patents and patents pending (less accumulated amortization
     of $78,697 and $123,930 in 1999 and 1998, respectively)                38,333               45,187

Other assets                                                                 5,917                5,917
                                                                         ---------            ---------
TOTAL ASSETS                                                            $1,335,649           $1,728,678
                                                                        ==========           ==========

                      LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities:
     Current maturities of long term debt (Note 6)                         $10,503              $55,438
     Short term loans-related parties (Note 13)                             88,000                    -
     Revolving Line of Credit (Note 5)                                     199,948               50,000
     Accounts payable                                                      324,192              405,009
     Accrued expenses (Note 7)                                             267,948              353,776
                                                                        ----------            ----------
                  Total current liabilities                                890,591              864,223
                                                                        ----------            ---------

Long term debt, less current maturities (Note 6)                            37,293              577,815
Noncurrent rent payable                                                      9,083                8,083
                                                                        ----------            ---------
                  Total liabilities                                        936,967            1,450,121
                                                                        ----------            ---------

Commitments and Contingencies (Note 8)                                           -                    -

Stockholders' Equity
     Common stock, $.01 par value;  12,000,000 shares authorized,
       6,281,667 and 4,374,387 issued and outstanding in 1999
       and 1998, respectively                                               62,817               43,744
     Additional paid-in capital                                          4,735,975            3,824,221
     Accumulated deficit                                                (4,400,110)          (3,589,408)
                                                                        ----------           ----------
                  Total stockholders' equity                               398,682              278,557
                                                                        ----------           ----------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                              $1,335,649           $1,728,678
                                                                        ==========           ==========
</TABLE>

                               See notes to financial statements.
<PAGE>
<TABLE>
                              SONO-TEK CORPORATION

                            STATEMENTS OF OPERATIONS
<CAPTION>

                                                                               Years Ended February 28,
                                                                   --------------------------------------------------
                                                                     1999                1998                 1997
                                                                     ----                ----                 ----
<S>                                                                <C>                 <C>                 <C>

Net Sales (Note 14)                                                $2,902,951          $3,570,379          $3,110,672
Cost of Goods Sold                                                  1,616,617           1,740,217           1,518,971
                                                                    ---------           ---------           ---------
                  Gross Profit                                      1,286,334           1,830,162           1,591,701
                                                                    ---------           ---------           ---------

Operating Expenses
     Research and product development
      expenses                                                        487,788             409,722             369,133
     Marketing and selling expenses                                   707,215             723,919             630,295
     General and administrative expenses                              498,517             395,954             377,037
     Non-cash charge for conversion of debt (Note 10)                 354,280                   -                   -
                                                                    ---------           ---------           ---------
                  Total Operating Expenses                          2,047,800           1,529,595           1,376,465
                                                                    ---------           ---------           ---------

Operating (Loss) Income                                              (761,466)            300,567             215,236

Interest Expense                                                      (60,448)            (48,888)            (66,789)

Interest and Other Income                                              11,212                 368               4,192
                                                                     --------            --------            --------
(Loss) Income Before Income Taxes                                    (810,702)            252,047             152,639

Income Tax Expense (Note 9)                                                 -                   -                   -
                                                                     --------            --------            --------

Net (Loss) Income                                                   $(810,702)           $252,047            $152,639
                                                                    =========            ========            ========


Basic (Loss) Earnings Per Share                                       ($0.18)              $0.06              $0.04
                                                                       ======              =====              =====

Diluted (Loss) Earnings Per Share                                     ($0.18)              $0.05              $0.03
                                                                       ======              =====              =====


Weighted Average Shares - Basic                                     4,386,799           4,346,064           4,204,913
                                                                    =========           =========           =========

Weighted Average Shares - Diluted                                   4,386,799           4,773,667           4,507,441
                                                                    =========           =========           =========
</TABLE>

                                       See notes to financial statements.

<PAGE>

<TABLE>
                              SONO-TEK CORPORATION

                 STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIENCY)

                  YEARS ENDED FEBRUARY 28, 1999, 1998 and 1997

<CAPTION>

                                        Common Stock                                                           Total
                                       Par Value $.01              Additional                              Stockholders'
                                     -----------------------        Paid-In            Accumulated            Equity
                                     Shares        Amount           Capital              Deficit           (Deficiency)
                                     ------        ------           -------              -------           ------------
<S>                                 <C>              <C>           <C>                <C>                   <C>

Balance - March 1, 1996             4,204,913        $42,049       $3,758,128         $(3,994,094)          $(193,917)

Net Income                                  -              -                -             152,639             152,639
                                    ---------        -------       ----------         -----------           ---------
Balance - February 28, 1997         4,204,913         42,049        3,758,128          (3,841,455)            (41,278)

Issuance of common stock              169,474          1,695           66,093                   -              67,788

Net Income                                  -              -                -             252,047             252,047
                                    ---------        -------       ----------         -----------           ---------
Balance - February 28, 1998         4,374,387         43,744        3,824,221          (3,589,408)            278,557

Issuance of common stock                4,000             40            1,280                   -               1,320

Subordinated Debt conversion        1,766,667         17,667          866,613                   -             884,280

Interest conversion                   136,613          1,366           39,618                   -              40,984

Non-employee stock option                   -              -            4,243                   -               4,243

Net Loss                                    -              -                -            (810,702)           (810,702)
                                    ---------        -------       ----------         -----------            --------
Balance - February 28, 1999         6,281,667        $62,817       $4,735,975         $(4,400,110)           $398,682
                                    =========        =======       ==========         ===========            ========
</TABLE>

                        See notes to financial statements.
<PAGE>
<TABLE>
                              SONO-TEK CORPORATION
                            STATEMENTS OF CASH FLOWS
<CAPTION>

                                                                                 Years Ended February 28,
                                                                   --------------------------------------------------
                                                                       1999                1998                1997
                                                                       ----                ----                ----
<S>                                                                 <C>                  <C>                 <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
    Net (Loss) Income                                               $(810,702)           $252,047            $152,639
    Adjustments to reconcile net (loss) income to net
       cash (used in) provided by operating activities:
          Non-cash charge for conversion of debt                      354,280                   -                   -
          Non-cash charge for stock options                             4,243                   -                   -
          Depreciation and amortization                                44,941              37,182              61,298
          Provision (benefit) for doubtful accounts                     5,000             (34,814)             11,500
          (Increase) decrease in:
              Accounts receivable                                     541,343            (244,368)            (75,135)
              Inventories                                            (171,741)           (146,218)              8,140
              Prepaid expenses and other current assets               (26,258)             (1,131)             (3,607)
              Other assets                                                  -              13,564                   -
          Increase (decrease) in:
              Accounts payable and accrued expenses                  (125,661)            204,518              25,281
              Non-current rent payable                                  1,000               7,417              (9,551)
                                                                    ---------            --------            --------
       Net Cash (Used In) Provided by Operating Activities           (183,555)             88,197             170,565
                                                                    ----------           --------            --------

CASH FLOWS FROM INVESTING ACTIVITIES-
   Purchase of equipment and furnishings                              (43,964)            (95,011)            (15,634)
                                                                     --------            --------             -------

CASH FLOWS FROM FINANCING ACTIVITIES:
   Repayment of notes and obligations payable -
    professional fees                                                       -                   -             (18,472)
   Repayments of notes payable - lease termination                          -                   -             (23,339)
   Payments on capital leases                                               -                   -              (1,753)
   Repayments of note payable, bank                                   (46,253)            (94,173)            (72,654)
   Repayments of equipment loan                                        (9,204)                  -                   -
   Proceeds from revolving line of credit                             149,948              50,000                   -
   Proceeds from equipment loan                                             -              57,000                   -
   Proceeds from short term loans-related parties                      88,000                   -                   -
   Proceeds from sale of common stock                                   1,320                   -                   -
                                                                      -------             -------            --------
       Net Cash Provided by (Used in) Financing Activities            183,811              12,827            (116,218)
                                                                      -------             -------            --------

NET (DECREASE) INCREASE IN CASH AND
        CASH EQUIVALENTS                                              (43,708)              6,013              38,713

CASH AND CASH EQUIVALENTS
   Beginning of year                                                  113,759             107,746              69,033
                                                                      -------            --------            --------
   End of year                                                        $70,051            $113,759            $107,746
                                                                      =======            ========            ========

SUPPLEMENTAL DISCLOSURE:
   Interest paid                                                      $17,960             $29,208             $51,419
                                                                      =======             =======             =======
   Non-cash exchange of accrued interest
    for common stock (Note 10)                                        $40,984             $67,788                   -
                                                                      =======             =======             =======
   Conversion of debt to equity (Note 10)                            $884,280                   -                   -
                                                                      =======             =======             =======

                                       See notes to financial statements.
</TABLE>
<PAGE>
                              SONO-TEK CORPORATION
                          NOTES TO FINANCIAL STATEMENTS
                    YEARS ENDED FEBRUARY 28, 1999, 1998 AND 1997

1.       BUSINESS DESCRIPTION

         The  Company  was  incorporated  in New York on March 21,  1975 for the
         purpose  of  engaging  in the  development,  manufacture,  and  sale of
         ultrasonic liquid atomizing nozzles.  Ultrasonic nozzle systems atomize
         low to medium viscosity  liquids by converting  electrical  energy into
         mechanical motion in the form of high frequency (ultrasonic) vibrations
         which break  liquids  into minute drops that can be applied to surfaces
         at low velocity.

2.       SIGNIFICANT ACCOUNTING POLICIES

         Cash and Cash Equivalents - Cash and cash equivalents  consist of money
         market  mutual  funds  and  short-term  certificates  of  deposit  with
         maturities of 90 days or less.

         Inventories  -  Inventories  are stated at the lower of cost or market.
         Cost is determined using the first-in,  first-out (FIFO) method for raw
         materials,   subassemblies  and   work-in-progress   and  the  specific
         identification  method for finished goods.  Consignment goods are spare
         parts used by  outside  sales  representatives  for  emergency  repairs
         performed on customer's equipment.

         Equipment and  Furnishings - Equipment  and  furnishings  are stated at
         cost.  Depreciation  of equipment and furnishings is computed by use of
         the  straight-line  method based on the  estimated  useful lives of the
         assets which range from five to ten years.

         Product Warranty - Expected future product warranty expense is recorded
         when the product is sold.

         Patent  and Patent  Pending  Costs - Costs of patent  applications  are
         deferred and charged to operations  over  seventeen  years for domestic
         patents and twelve years for foreign  patents.  However,  if it appears
         that such costs are  related to products  which are not  expected to be
         developed for commercial  application within the reasonably foreseeable
         future,  or are  applicable  to  geographic  areas where the Company no
         longer requires patent protection, they are written-off to operations.

         Research  and  Product  Development  Expenses  - Research  and  product
         development  expenses  represent  engineering  and  other  expenditures
         incurred for  developing  new  products,  for  refining  the  Company's
         existing  products and for developing  systems to meet unique  customer
         specifications  for potential  orders or for new industry  applications
         and are expensed as incurred.  Engineering costs directly applicable to
         the  manufacture  of existing  products  are  included in cost of goods
         sold.

         Income  Taxes - The Company  accounts  for income taxes under the asset
         and  liability  method.  Under this method,  deferred  income taxes are
         recognized  for the tax  consequences  of  "temporary  differences"  by
         applying  enacted  statutory  tax rates  applicable  to future years to
         differences  between the financial  statement  carrying amounts and the
         tax basis of existing assets and liabilities. If it is more likely than
         not that  some  portion  or all of a  deferred  tax  asset  will not be
         realized, a valuation allowance is recognized.

         Earnings  (Loss)  Per  Share - Basic  earnings  per  share  ("EPS")  is
         computed by dividing net income (loss) by the  weighted-average  number
         of common shares  outstanding for the period.  Diluted EPS reflects the
         potential dilution that could occur if securities or other contracts to
         issue common stock were exercised or converted into common stock. Stock
         options  granted but not yet exercised under the Company's stock option
         plans are  included  for Diluted EPS  calculations  under the  treasury
         stock method. The convertible secured subordinated promissory notes and
         related  warrants (see Note 6) were  antidilutive and therefore are not
         considered for the Diluted EPS calculations.

         Advertising  Expenses - The Company expenses the cost of advertising in
         the period in which the advertising  takes place.  Advertising  expense
         for the years ended  February  28,  1999,  1998 and 1997 was  $110,805,
         $113,153, and $102,439, respectively.

         Long-Lived  Assets - The Company  periodically  evaluates  the carrying
         value of long-lived assets,  including  intangible assets,  when events
         and  circumstances  warrant  such a  review.  The  carrying  value of a
         long-lived   asset  is  considered   impaired   when  the   anticipated
         undiscounted  cash flow from such asset is separately  identifiable and
         is less than its carrying  value.  In that event,  a loss is recognized
         based on the amount by which the carrying value exceeds the fair market
         value  of  the  long-lived  asset.  Fair  market  value  is  determined
         primarily  using  the  anticipated  cash  flows  discounted  at a  rate
         commensurate with the risk involved.

         Stock-Based   Employee   Compensation   -  The  Company   accounts  for
         stock-based  compensation  plans utilizing the provisions of Accounting
         Principles Board Opinion No. 25 (APB 25),  "Accounting for Stock Issued
         to  Employees"  and the  Financial  Accounting  Statement  of Financial
         Accounting  Standards No. 123 (SFAS 123),  "Accounting  for Stock-Based
         Compensation".  Under SFAS 123, the Company will  continue to apply the
         provisions  of  APB  25  to  its  stock-based   employee   compensation
         arrangements,   and  is  only  required  to  supplement  its  financial
         statements with additional proforma disclosures.

         Management  Estimates - The  preparation  of  financial  statements  in
         conformity  with  generally  accepted  accounting  principles  requires
         management to make estimates and  assumptions  that affect the reported
         amounts of assets and liabilities  and disclosure of contingent  assets
         and  liabilities  at the  date  of the  financial  statements  and  the
         reported amounts of revenues and expenses during the reporting  period.
         Actual results could differ from those estimates.

         Reclassifications  -  Certain  amounts  in  the  prior  year  financial
         statements  have been  reclassified  to  conform  to the  current  year
         presentation.

3.       INVENTORIES

         Inventories consist of the following:
<TABLE>
<CAPTION>
                                                        February 28,
                                              -------------------------------
                                                1999                   1998
                                                ----                   ----
                    <S>                       <C>                    <C>
                    Raw Materials             $591,536               $281,467
                    Work-in-process             56,119                160,450
                    Consignment                 10,868                      -
                    Finished Goods             128,677                173,542
                                               -------                -------
                                              $787,200               $615,459
                                              ========               ========
</TABLE>

4.       EQUIPMENT AND FURNISHINGS

         Equipment and furnishings consist of the following:
<TABLE>
<CAPTION>
                                                              February 28,
                                                     ------------------------------
                                                       1999                  1998
                                                       ----                  ----
                    <S>                              <C>                   <C>
                    Laboratory equipment             $ 79,441              $ 77,436
                    Machinery and equipment           324,444               289,576
                    Furniture and fixtures            131,493               124,402
                                                     --------              --------
                    Totals                            535,378               491,414
                    Less:  accumulated depreciation  (407,486)             (369,398)
                                                     --------              --------
                                                     $127,892              $122,016
                                                     ========              ========
</TABLE>

5.       REVOLVING LINE OF CREDIT
         On January  2, 1998,  the  Company  received a $150,000  line of credit
         which  carries an interest rate of prime plus 2% (9.75% at February 28,
         1999).  On February 15, 1999, the line of credit was  restructured  and
         increased  to  $300,000.   The  loan  is   collateralized  by  accounts
         receivable,  inventory and all other  personal  property of the Company
         and is  guaranteed  by the CEO of the  Company.  The line of  credit is
         payable on demand.  As of February  28, 1999 and 1998,  the balance was
         $199,948 and $50,000 respectively.

6.       LONG-TERM DEBT

         Long-term debt consists of the following:
<TABLE>
<CAPTION>
                                                                                                February 28,
                                                                                      -------------------------------
                                                                                        1999                   1998
                                                                                        ----                   ----

           <S>                                                                         <C>                   <C>
           Note payable, bank, collateralized by accounts receivable,  inventory
             and all other personal property of the Company.  As modified in May
             1996,  the note was  payable  in  monthly  installments,  including
             interest at 2% over the bank's  prime rate  (10.5% at February  28,
             1998), of $7,500.  The weighted average interest rate was 10.5% and
             10.4% during Fiscal 1999 and 1998, respectively.  The loan was
             personally guaranteed by the Company's President and a former
             Chairman and Chief Executive Officer of the Company.  The note was
             paid off in August 1998.                                                        -                 46,253

           Convertible  secured  subordinated  promissory notes, as amended with
             individuals,  collateralized by all of the personal property of the
             Company,  and  subordinate  to the note  payable to the bank or any
             successor  credit  facility up to $1,500,000.  Payable in quarterly
             installments  of interest at 1/2% under the prime rate in effect on
             August 15 of each year until  maturity on August 15,  2000.  In the
             original note,  each $1,000 portion of these notes was  convertible
             into  1,428  common  shares of the  Company  and a  warrant,  which
             expired in August 2000, to purchase an  additional  1,428 shares of
             common stock at $1.50 a share.  During Fiscal 1999, the Company was
             in default of the  agreement  for failure to pay interest when due.
             On February 26, 1999 the Note was amended to reduce the  conversion
             price from $0.70 to $0.30,  and the noteholders  converted.  At the
             same time the warrants were extended to February 28, 2002,  and the
             price was  reduced  to $0.65 per share (see Note 11).  These  notes
             included $50,000 issued to the Company's former Chairman of the Board.          -                530,000

           Equipment loan, bank, collateralized by related production equipment,
             payable in monthly installments of $1,225, including interest at 2%
             over the bank's prime rate (9.75% at February 28, 1999).                   47,796                 57,000
                                                                                       -------               --------
                           Total long term debt                                         47,796                633,253

                           Due within one year                                         (10,503)               (55,438)
                                                                                       -------               --------
                           Due after one year                                          $37,293               $577,815
                                                                                       =======               ========
</TABLE>

         Long-term debt is payable as follows (as of February 28, 1999):

                February 28, 2000            $10,503
                February 28, 2001             11,574
                February 28, 2002             12,754
                February 29, 2003             12,965
                                             -------
                                             $47,796
                                             =======

         Management believes that the fair value of the debt payable to the bank
         approximates  its carrying value because of the variable  interest rate
         on the loan.  Management  does not believe it is practical to determine
         the fair value of the convertible secured subordinated promissory notes
         as there are no similar  notes to compare  them to. As of February  28,
         1999 the  Company  was in  compliance  with the terms of the  covenants
         related to the bank loan.

7.       ACCRUED EXPENSES

         Accrued expenses consist of the following:
                                                         February 28,
                                               -------------------------------
                                                 1999                   1998
                                                 ----                   ----
                  Professional fees            $ 93,076               $ 88,576
                  Estimated warranty costs       17,800                 30,250
                  Accrued compensation          120,203                137,068
                  Accrued commissions             5,593                 70,480
                  Accrued interest                1,364                 20,253
                  Accrued claim                  25,000                      -
                  Other accrued expenses          4,912                  7,149
                                                -------               --------
                                               $267,948               $353,776
                                               ========               ========

8.       COMMITMENTS AND CONTINGENCIES

         Litigation  - During  the  normal  course of  business  the  Company is
         involved in various  routine legal  matters.  The Company  believes the
         outcome of these matters will not have a material adverse effect on the
         Company's financial statements.

         Leases - The Company leases an office and manufacturing  facility under
         a lease that  expired in January  1997.  The lease  provided for a five
         year renewal option at annual rentals  varying from $65,000 to $78,000,
         but that option was not exercised.  The Company is making payments on a
         month-to-month  basis equal to the amount that would have been required
         per month if the option had been exercised.

         Rent expense was approximately  $73,000,  $73,000,  and $61,000 for the
         years ended February 28, 1999, 1998, and 1997, respectively.

9.       INCOME TAXES

         The annual  provision  (benefit)  for income taxes differs from amounts
         computed  by  applying  the  maximum  U.S.  Federal  income tax rate to
         pre-tax income (loss) as follows:

<TABLE>
<CAPTION>
                                                                               February 28,
                                                   ------------------------------------------------------------------
                                                      1999       %             1998      %             1997        %
                                                      ----       -             ----      -             ----        -
              <S>                                  <C>         <C>           <C>        <C>          <C>         <C>
              Computed tax (benefit)
              expense at maximum rate              ($275,639)  (34.0)        $85,700    34.0         $52,700     34.0

              Permanent differences                    2,574      .3           1,330      .5               -        -
              Tax effect of debt
                  conversion costs                   121,898    15.0               -     -                 -        -
              Change in valuation
                  allowance for tax
                  effect of operating
                  loss carryforwards                 151,167    18.7         (87,030)  (34.5)        (52,700)   (34.0)
                                                     -------                 -------    ----         -------     ----
              Provision for
                  income taxes                     $      -        -         $     -       -         $     -        -
                                                   ========    =====         =======    ====         =======     ====
</TABLE>

         The net deferred tax asset is comprised of the following:
<TABLE>
<CAPTION>

                                                                                  February 28,
                                                                     -------------------------------------
                                                                         1999                       1998
                                                                         ----                       ----
              <S>                                                     <C>                       <C>
              Allowance for doubtful accounts                         $    2,000                $        0
              Accumulated depreciation                                    24,000                    24,000
              Accumulated amortization                                     8,000                     8,000
              Inventory                                                   52,000                    19,000
              Noncurrent rent payable                                      4,000                     3,000
              Accrued vacation                                            10,000                    11,000
              Accrued expenses                                            60,000                    57,000
              Operating loss carryforwards                             1,452,000                 1,283,000
                                                                       ---------                 ---------

              Net deferred tax assets before
                           valuation allowance                         1,612,000                 1,405,000
              Deferred tax asset valuation allowance                  (1,612,000)               (1,405,000)
                                                                       ---------                 ----------

              Net deferred tax asset                                  $       -                 $        -
                                                                      ==========                ==========
</TABLE>

         The change in the valuation  allowance was $207,000 and  ($123,000) for
         the years ended February 28, 1999 and 1998, respectively.

         At  February  28,  1999,  the  Company  has  available  operating  loss
         carryforwards of approximately $3,632,000 for income tax purposes which
         expire between 2001 and 2019.

10.      CAPITAL STOCK

         On April 30, 1997, the Company reached an agreement with the holders of
         $530,000 of secured convertible secured subordinated  promissory notes,
         whereby they agreed to, among other things,  accept  169,474  shares of
         the Company's  Common Stock as payment for the total amount of interest
         due as of February 28, 1997 of $67,788.  During Fiscal 1999, as part of
         the Fourth Note Amendment Agreement,  the Noteholders agreed to convert
         $530,000  of  convertible  secured  subordinated  promissory  notes  on
         February 26, 1999 into 1,766,667  shares of the Company's Common Stock.
         Also, as part of the Fourth Note Agreement,  the  Noteholders  received
         136,613  shares of the Company's  Common Stock as payment for the total
         amount of interest due as of February 26, 1999.  The Agreement  lowered
         the  conversion  price  from  $.70 per  share to $.30 per  share.  This
         resulted in a non-cash  charge of $302,857 to earnings for Fiscal 1999.
         An additional non-cash charge of $51,423 was the result of the lowering
         of the  warrant  exercise  price from $1.50 per share to $.65 per share
         (see Note 11).

11.      STOCK OPTIONS AND WARRANTS

         Stock  Options - Under the 1993 Stock  Incentive  Plan,  ("1993  Plan")
         options  can  be  granted  to  officers,  directors,   consultants  and
         employees  to purchase up to 750,000 of the  Company's  common  shares.
         Options  granted  under the 1993 Plan expire on various  dates  through
         2003.

         Under the 1993 Stock  Incentive  Plan,  option  prices must be at least
         100% of the fair market value of the common stock at time of grant. For
         qualified employees,  except under certain  circumstances  specified in
         the 1993 plan or unless  otherwise  specified at the  discretion of the
         Board of Directors,  no option may be exercised prior to one year after
         date of grant,  with the balance  becoming  exercisable  in  cumulative
         installments  over a three year  period  during the term of the option,
         and  terminate  at a  stipulated  period  of time  after an  employee's
         termination of employment.

         During  Fiscal 1999,  the Company  granted  options for 172,500  shares
         exercisable  at between  $.38 per share and $.60 per share to qualified
         employees,  and  20,000  shares  exercisable  at $.30  per  share  to a
         consultant of the Company.  During Fiscal 1999 compensation  expense of
         $4,243 was  recognized  based on the fair value of fully vested options
         granted to  non-employees.  During  Fiscal  1998,  the Company  granted
         options for 299,000  shares  exercisable  at between $.37 per share and
         $.82 per share to qualified employees.  During Fiscal 1997, the Company
         granted to qualified  employees  17,500 shares  exercisable at $.78 per
         share  and 5,124  shares,  exercisable  at $.625  per share to  outside
         consultants.

         A summary of the 1993 Plan  activity  for the three year  period  ended
        February 28, 1999 is as follows:

<TABLE>
<CAPTION>
                                                       Stock Options                        Exercise Price
                                            Outstanding             Exercisable      Outstanding      Exercisable
                                            -----------             -----------      -----------      -----------
         <S>                                       <C>                <C>              <C>              <C>
         Balance -March 1, 1996                    283,500            131,450          $ .37            $ .37
         Granted - Fiscal 1997                      22,624                               .74
         Canceled - Fiscal 1997                     (2,500)                              .38)
                                                   -------            -------          -----            -----
         Balance - February 28, 1997               303,624            221,544            .40              .35
         Granted Fiscal 1998                       299,000                               .42
         Canceled Fiscal 1998                      (45,000)                             (.52)
                                                   -------            -------          -----            -----
         Balance - February 28, 1998               557,624            457,875            .40              .38
         Granted Fiscal 1999                       192,500                               .55
         Canceled Fiscal 1999                      (43,500)                             (.39)
         Exercised Fiscal 1999                      (4,000)                             (.33)
                                                   -------                             -----
         Balance - February 28, 1999               702,624            512,049          $ .44            $ .39
                                                   =======            =======          =====            =====
</TABLE>

         The fair value of  options  granted  under the  Company's  fixed  stock
         option plans during  Fiscal 1999,  1998 and 1997 were  estimated on the
         dates of grant using the minimum value options-pricing  models with the
         following  weighted-average  assumptions used:  expected  volatility of
         approximately  83%,  75%  and  60%  in  Fiscal  1999,  1998  and  1997,
         respectively,  risk free interest rate of  approximately  5.25%, 6% and
         6.3% in Fiscal 1999, 1998 and 1997, respectively, and expected lives of
         option grants of approximately five years.

         The estimated fair value of options  granted  during Fiscal 1999,  1998
         and 1997  were  $.25 per  share,  $.17 per  share  and $.20 per  share,
         respectively.  The Company applies Accounting  Principles Board Opinion
         No. 25 and related interpretations in accounting for the 1993 Plan. Had
         compensation  cost for the Company's  stock option plan been determined
         based on the  fair  value at the  option  grant  dates  for  awards  in
         accordance  with the  accounting  provisions of SFAS 123, the Company's
         net income (loss) and basic and diluted  earnings  (loss) per share for
         the years  ended  February  28,  1999,  1998 and 1997  would  have been
         changed to the pro forma amounts indicated below:
<TABLE>
<CAPTION>

                                                      1999            1998               1997
                                                      ----            ----               ----
         <S>                                       <C>              <C>                <C>
         Net (Loss)Income:
                As reported                        $(810,702)       $252,047           $152,639
                Pro forma                          $(882,675)       $210,896           $147,229
         Basic earnings (loss) per share:
                As reported                          $(.18)           $.06               $.04
                Pro forma                            $(.20)           $.05               $.04

         Diluted earnings (loss) per share (see Note 12):
                As reported                          $(.18)           $.05               $.03
                Pro forma                            $(.20)           $.04               $.03
</TABLE>
         Warrants - In connection with the conversion of the Convertible Secured
         Subordinated  Promissory  Notes (see Note 6), on February  26, 1999 the
         Company  modified the terms of the original  detachable  stock warrants
         reducing  the  exercise  price from $1.50 per share to $0.65 per share.
         After conversion of the note,  there are 756,840 warrants  outstanding.
         The estimated fair value of these warrants at the date issued was $0.07
         per share using the minimum value options-pricing model and assumptions
         similar  to those  used for  valuing  the  Company's  stock  options as
         described  above,  except the  expected  lives of the  warrants  is two
         years. A non-cash charge for conversion of debt of $51,423 was recorded
         in connection with the issuance of these warrants.

12.      EARNINGS (LOSS) PER SHARE

         The  following  table sets forth the  computation  of basic and diluted
         earnings (loss) per share:
<TABLE>
<CAPTION>

                                                                                      February 28,
                                                                   -----------------------------------------------
                                                                       1999              1998                1997
                                                                       ----              ----                ----
         <S>                                                        <C>               <C>                 <C>
         Numerator-
           Numerator for basic and diluted earnings
              (loss) per share - net (loss) income                  $(810,702)        $252,047            $152,639
                                                                    ==========        ========            ========

         Denominator:
           Denominator for basic earnings (loss) per
               share -weighted average shares                       4,386,799        4,346,064           4,204,913
           Effects of dilutive securities:
              Stock options for employees
              and outside consultants                                       0*         427,603             302,528
                                                                    ---------        ---------          ----------

           Denominator for diluted earnings (loss)
              per share                                             4,386,799**      4,773,667**         4,507,441**
                                                                    =========        =========           =========

         Basic Earnings (Loss) Per Share                             $(.18)             $.06               $.04
                                                                     ======             ====               ====

         Diluted Earnings (Loss) Per Share                           $(.18)***          $.05***            $.03***
                                                                     ======             ====               ====
</TABLE>

         * Stock options for employees and outside  consultants are antidilutive
         during  Fiscal 1999 as a result of the net loss and  therefore  are not
         considered in the Diluted EPS calculation.

         **The effect of considering  the warrants issued in connection with the
         debt conversion during Fiscal 1999 (see Notes 6 and 11) at February 28,
         1999 and the  convertible  secured  subordinated  promissory  notes and
         related warrants (see Notes 6 and 11) at February 28, 1998 and 1997 are
         antidilutive  and  therefore  not  considered  for the  diluted  (loss)
         earnings per share calculations.

         ***Under  the  assumption  that stock  options  and  warrants  were not
         antidilutive  as  described  in * and **, the  denominator  for diluted
         earnings (loss) per share would be 5,766,578,  5,530,507, and 5,264,281
         at February 28, 1999, 1998 and 1997, respectively.


13.      RELATED PARTY TRANSACTIONS

         Short term loans - related  parties - From time to time the Company has
         required short term loans to meet its cash  requirements.  All of these
         loans have been  provided by two Board  members of the Company,  one of
         which is an  officer,  at the rate of prime plus 2% (9.75% at  February
         28, 1999). As of February 28, 1999 the amount  outstanding was $88,000.
         During  Fiscal  1999,  interest  expense  relating  to these  loans was
         $1,354.

         Consulting  agreement - At February  28, 1999 and  February  28,  1998,
         accounts payable includes a liability for prior years'  consulting fees
         to the Company's  former Chairman of the Board of $69,076 recorded from
         1993 to 1996.

14.      SIGNIFICANT CUSTOMERS AND FOREIGN SALES

         For the year ended February  28,1999 one customer  accounted for 17% of
         sales. At February 28, 1999,  this customer  accounted for 29% of trade
         receivables. No single customer accounted for more than 10% of sales or
         trade  receivables  for the years ended  February 28, 1998 and February
         28, 1997.

         Export sales to customers  located outside the United States were
         approximately as follows:

<TABLE>
<CAPTION>

                                                                                 February 28,
                                                         ------------------------------------------------------------
                                                           1999                      1998                      1997
                                                           ----                      ----                      ----
             <S>                                         <C>                       <C>                       <C>
             Western Europe                              $235,000                  $ 41,000                  $399,000
                   Far East                               100,000                   163,000                   164,000
                      Other                               285,000                   231,000                   116,000
                                                          -------                   -------                   -------
                                                         $620,000                  $435,000                  $679,000
                                                         ========                  ========                  ========
</TABLE>

15.      FINANCIAL CONSIDERATIONS AND MANAGEMENT'S PLANS

         The  Company  incurred  a net  loss  during  Fiscal  1999 of  $810,702,
         consisting of a loss from  operations and a non-cash charge of $354,280
         resulting from the conversion of the Convertible  Secured  Subordinated
         Promissory  Note to equity.  The  operating  loss was a result of lower
         sales  stemming  from a down turn in the  capital  goods  market in the
         electronics  industry. In response to the loss, the Company initiated a
         series of cost  reductions,  lowered interest expense by converting the
         Convertible  Secured  Subordinated  Promissory Notes, and increased its
         efforts to expand the customer base outside of the electronics  market.
         Management   also   anticipates  the  acquisition  of  a  company  that
         manufactures   cleaning,   rinsing   and   drying   systems   for   the
         semiconductor,  disk drive,  precision  parts  manufacturing,  and flat
         panel  display  industries,   (see  Note  16)  will  give  the  Company
         additional  sales,  and the ability to reduce overhead costs by sharing
         the costs between the two companies.

         As necessary,  the Company plans on funding the operations by using the
         available  borrowings  under the current line of credit  agreement  and
         obtaining loans from shareholders (as required in the past).

         Although the results of these actions  cannot be  predicted,  including
         the success of the  acquisition  and the  ability to derive  sufficient
         cash flows from the new acquisition (See Note 16), the Company believes
         that these steps are  appropriate  and will help the Company  return to
         profitability in Fiscal 2000.

16.      SUBSEQUENT EVENTS

         During the first  quarter of Fiscal  2000,  two Board  members,  one of
         which is an  officer,  provided  short term loans to the Company in the
         amount of $77,000  bringing  the total  loans from  related  parties to
         $165,000.

         On March 3, 1999, as part of the Company's  plan to grow and diversify,
         the Company  signed a  non-binding  letter of intent to acquire a local
         manufacturer of specialty equipment that produces cleaning,  degreasing
         and vapor drying systems for the  semiconductor,  disk drive, and other
         high technology industries.  The Company believes this acquisition will
         complement  the Company's  core business  including  industry focus and
         manufacturing similarities.  The Company also believes that significant
         efficiencies  can be realized by  integrating  the operation of the two
         companies.  The Company anticipates  reporting this transaction on Form
         8-K upon the execution of a definitive acquisition agreement.

         On May 5, 1999 the  Company  released  a Private  Placement  Memorandum
         which offers  1,666,667  shares of the Company's  common stock at $0.30
         per share.  The money  raised from this  offering  will be used for the
         planned acquisition,  as discussed in the proceeding paragraph,  and as
         working capital.

         At a meeting held May 13, 1999,  the Board of Directors  granted a five
         year stock purchase warrant for 300,000 shares, exercisable at $.30 per
         share to each of the two Board  members  who have  loaned  money to the
         Company  over the last several  years.  The Board also  authorized  the
         grant of 100,000  shares of the Company's  common stock to the CEO upon
         the completion of the acquisition discussed above. At the same meeting,
         a non-employee director was granted 20,000 options, exercisable at $.30
         per share,  of which 10,000 were vested  immediately and 10,000 vest at
         the end of his current term as a director.
<PAGE>
                                   SCHEDULE II
<TABLE>


                              SONO-TEK CORPORATION

                        VALUATION AND QUALIFYING ACCOUNTS
<CAPTION>


                                                                  Column C
Column A                            Column B                     Additions               Column D           Column E
- ---------------------------------------------------------------------------------------------------------------------
                                     Balance       Charged (credited)     Charged to                        Balance
                                  at Beginning         to Costs and        to Other                          at End
Description                         of Period            Expenses          Accounts       Deductions*       of Period
- -----------                         ---------            --------          --------       -----------       ---------

Allowance for doubtful accounts:
   <S>                                <C>               <C>                 <C>              <C>             <C>

   Year Ended February 28, 1999       $1,000             $5,000             -                $ 0             $6,000

   Year Ended February 28, 1998       35,814            (34,814)            -                  0              1,000

   Year Ended February 28, 1997       25,000             11,500             -                686             35,814
</TABLE>

* Represents write-offs, net of recoveries, of uncollectible accounts.


<PAGE>


SIGNATURES

Pursuant to the  requirements of Section 13 or 15(d) of the Securities  Exchange
Act of 1934,  the  Registrant  has duly  caused  this report to be signed on its
behalf by the undersigned, thereto duly authorized.

Dated: June 1, 1999

Sono-Tek Corporation
(Registrant)

By: /s/ James L. Kehoe
- ----------------------
         James L. Kehoe
         Chairman and Chief Executive Officer

KNOW ALL MEN BY THESE PRESENTS,  that the undersigned  directors and officers of
Sono-Tek Corporation, a New York corporation,  which is filing its Annual Report
on Form 10-K with the Securities and Exchange Commission under the provisions of
the Securities  Exchange Act of 1934, as amended,  hereby constitute and appoint
James L.  Kehoe and  Kathleen  N.  Martin and each of them their true and lawful
attorney-in-fact   and   agent,   with   full   power   and   substitution   and
re-substitution, for him and her and in his or her name, place and stead, in any
and all capacities, to sign such Form 10-K and any or all amendments to the Form
10-K,  and all other  documents  in  connection  therewith  to be filed with the
Securities  and Exchange  Commission,  granting unto said  attorney-in-fact  and
agent full power and  authority  to do and perform  each and every act and thing
requisite and  necessary to be done in and about the  premises,  as fully to all
interests  and  purposes  as each of them  might or could do in  person,  hereby
ratifying  and  confirming  all  that  said  attorney-in-fact  and  agent or his
substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following  persons on behalf of the  Registrant and
in the capacities and on the dates indicated.

/s/ James L. Kehoe         June 1, 1999
- ------------------
James L. Kehoe
Chairman, Chief Executive Officer and Director

/s/ John J. Antretter      June 1, 1999    /s/ Harvey L Berger      June 1, 1999
- ---------------------                        -------------------
John J. Antretter                            Harvey L. Berger
Director                                     President and Director

/s/ Christopher L. Coccio  June 1, 1999   /s/ Samuel Schwartz       June 1, 1999
- -------------------------                    -------------------
Christopher L. Coccio                        Samuel Schwartz
Director                                     Director

/s/ J. Duncan Urquhart     June 1, 1999   /s/ Kathleen N. Martin    June 1, 1999
- ----------------------                       ----------------------
J. Duncan Urquhart                           Kathleen N. Martin
Director                                     Treasurer & Chief Financial Officer


<PAGE>


Exhibit 4(i)  Form of 1999 Amendment to Convertible Note

                         FOURTH NOTE AMENDMENT AGREEMENT

Reference  is made to that certain  Convertible  Secured  Subordinated  Note (as
amended,  the "Note") by and between  Sono-Tek  Corporation  (the "Company") and
NAME~ (the  "Holder") in the principal  amount of $DOLLARS~  made as of November
16, 1993, as amended by the Note Amendment  Agreement made as of March 23, 1995,
the Second Note  Amendment  Agreement  made as of April 30, 1996,  and the Third
Note Amendment Agreement made as of April 30, 1997.

Whereas the Company has not made several interest  payments to Holder which were
due on the dates and in the amounts shown in Attachment I hereto, and

Whereas the failure of the Company to make said  interest  payments on the dates
due  constitutes  (or in the case of the interest  payment due February 15, 1999
will, with the passage of time constitute)  events of default in accordance with
the terms of the Note, and

Whereas the Company may not be able to repay the principal amount of the Note in
the amount stated above when such amount becomes due on August 15, 2000, and

Whereas the Board of Directors of the Company unanimously agreed on February 19,
1999 to reduce  the  conversion  price of the Note from $0.70 per share to $0.30
per share;

Now, therefore, the Company and the Holder hereby agree as follows:

1.   The Holder  hereby  agrees and elects to convert the entire Note,  the past
     due interest on the Note, and interest due on the past due interest, all as
     shown in Attachment I hereto,  into Common stock of the Company at the rate
     of $0.30 per share.  The Holder and the Company  agree that rounding to the
     nearest  whole share will be in lieu of a cash  payment for any  fractional
     share.
2.   Upon the signing  hereof and the  surrender  of the Note,  the Company will
     promptly issue  instructions  to it's transfer agent to issue to the Holder
     certificates  for a  total  of  SHARES~  shares  of its  common  stock,  in
     denominations  as shown in  Attachment  I  hereto.  Certificates  for these
     shares shall bear the restrictive legend set forth in Attachment II hereto.
3.   The Company  agrees to use its  reasonable  best  efforts to  register  the
     shares issued in connection with this Agreement within one year of the date
     hereof,  unless  the  Company  shall  furnish  an opinion of counsel to the
     Company that such  registration is not required under the Securities Act of
     1933 or unless the shares are eligible for sale  pursuant to Rule 144 under
     such Act.
4.   The Holder hereby waives all events and prospective events of default under
     the Note (including those described above) and will not seek to enforce any
     rights or remedies  against the Company  provided in the Note or  otherwise
     based on or resulting from such defaults.
5.   The Company hereby extends the expiration  date of the Warrant to be issued
     to the Holder upon  conversion of the Note from August 15, 2000 to February
     28, 2002,  and further  agrees to reduce the exercise price of said Warrant
     from $1.50 per share to $0.65 per  share.  The  Holder  agrees  that if the
     common  stock of Sono-Tek  trades at a price equal to or greater than $1.95
     per share for a period of thirty (30)  consecutive  days, the Company shall
     have the right to require  that the  warrant be  exercised  at the  reduced
     exercise price of $0.65 within ninety (90) days of providing  notice to the
     Holder of such event. If the Warrant is not exercised as herein  described,
     the Company  shall have the right to  repurchase  the Warrant at $0.001 per
     share.  The Holder  agrees that the Warrant to be issued to the Holder will
     reflect the provisions of this paragraph 5.
6.  Holder,  by his  signature  hereto,  agrees  to all  of  the  provisions  of
Attachment II hereto.

Sono-Tek Corporation                                          February 26, 1999

- ---------------                                                  ---------------
James L. Kehoe                                                   NAME
Chief Executive Officer

<PAGE>


Fourth Note Amendment Agreement - Attachment II

The undersigned understands, agrees, represents and warrants as follows:

1.   The shares referred to in paragraph 1 of the Fourth Note Amendment
     Agreement are referred to as the "Shares" in this Attachment II.

2.   Holder's right to transfer the Shares will be highly restricted. The Shares
     may not be  transferred  except (a) pursuant to an  effective  registration
     statement under the Securities Act of 1933, as amended (the "Act"), (b) if,
     in the  opinion  of  counsel  to the  Company,  such  transfer  may be made
     pursuant to an exemption from the registration  requirements of the Act, or
     (C)  pursuant to SEC Rule 144 under the Act.  Holder is  familiar  with the
     provisions of Rule 144,  including  without  limitation the holding periods
     required by said Rule. Holder is prepared to bear the economic risk of this
     investment for an indefinite period of time.


3.   The  certificates  for the Shares may bear a legend reading  substantially
     as follows:

          "These securities have not been registered under the Securities Act of
     1933.  They may not be sold,  offered for sale,  pledged,  hypothecated  or
     otherwise transferred in the absence of a registration  statement in effect
     with respect to the  securities  under such Act or an opinion of counsel to
     the Company that such  registration is not required or unless sold pursuant
     to Rule 144 under such Act."

     Appropriate  stop transfer  instructions  with respect to  certificates for
     the Shares will be placed with the Company's  transfer agent. 4. Holder is
     acquiring the Shares for Holder's own account for investment  purposes and
     not for sale or with a view to distribution of all or any part of such
     Shares. Holder agrees not to make any  transfer  of the Shares  unless  the
     Shares are the  subject of an effective  registration  statement under the
     Act or unless an exemption from the registration requirements of the Act is
     available.

5.   The Company has provided Holder with all information,  documents, books and
     records  which Holder has  requested  for deciding  whether to purchase the
     Shares,  including  without  limitation  true and  complete  copies  of the
     Company's  Annual Report to Shareholders for its fiscal year ended February
     28, 1998; its definitive proxy statement dated July 13, 1998 for its annual
     meeting of  shareholders  held August 20, 1998,  its annual  report on Form
     10-K for its fiscal year ended February 28, 1998, its quarterly  reports on
     Form 10-Q for its fiscal  quarters ended May 31, 1998,  August 31, 1998 and
     November  30, 1998,  and its Form 8-A  amendment  No. 2 dated  February 23,
     1999.  Holder is aware that the Company has not made the interest  payments
     described  in the Fourth Note  Amendment  Agreement,  to any holders of the
     Company's Convertible Secured Subordinated Notes in the aggregate principal
     sum  of  $530,000.  Holder  confirms  that  Holder  has  been  granted  the
     opportunity to ask questions and receive answers from the Company regarding
     the terms and conditions of the offering of the Shares.

6.   Holder recognizes that investment in the Shares involves certain risks, and
     Holder  has  taken  full  cognizance  of and  understands  all of the risks
     related to the purchase of the Shares.  Holder is an "accredited  investor"
     within the meaning of SEC  Regulation D promulgated  under the Act, has the
     financial  sophistication,   knowledge  and  experience  in  financial  and
     business  matters  to  evaluate  and  analyze  the  merits  and risks of an
     investment  in the  Shares,  and is able to bear  the  risk of loss of such
     investment.  If Holder is a natural person, Holder represents that Holder's
     individual net worth, or joint net worth with that person's spouse, exceeds
     $1,000,000 or that Holder had an individual income in excess of $200,000 in
     each of the two most recent years or joint income with that person's spouse
     in  excess  of  $300,000  in  each of  those  years  and  has a  reasonable
     expectation  of reaching  the same income  level in the  current  year.  If
     Holder is not a natural person, Holder represents that it was not organized
     for the specific purpose of making this particular investment.

7.   This Attachment II is not transferable or assignable by Holder.

DATED: February 26, 1999                           ACCEPTED

- ------------------------------                     -----------------------------
NAME~    Sono-Tek Corporation
STREET~  James L. Kehoe
TOWN~    Chief Executive Officer
<PAGE>
Exhibit 4(j)  Mr. Kehoe's Personal Guarantee for the Bank of New York

THE
BANK OF
NEW                                          GENERAL GUARANTEE
YORK

285 Main Mall, Poughkeepsie                                    February 15, 1999
(Banking Office)


FOR VALUE RECEIVED,  and in  consideration of loans made or to be made or credit
otherwise  extended or to be extended by THE BANK OF NEW YORK (the "Bank") to or
for the account of Sono-Tek Corporation (the "Borrower") of 2012 Route 9W, Bldg.
3, Milton,  NY from time to time and at any time and for other good and valuable
consideration  and to induce the Bank, in its  discretion,  to make or commit to
make such loans or  extensions  of credit  and to make or grant  such  renewals,
extensions,  releases of  collateral or  relinquishments  of legal rights as the
Bank may deem advisable,  the undersigned  (jointly and severally,  if more than
one guarantor,  whether  executing the same instrument or separate  instruments)
absolutely  and  unconditionally  guarantees to the Bank the prompt payment when
due, whether by acceleration or otherwise,  of all present or future obligations
and  liabilities  of any and all  kinds of the  Borrower  to the Bank and of all
instruments  of any nature  evidencing or relating to any such  obligations  and
liabilities  upon which the  Borrower or one or more parties and the Borrower is
or may become  liable to the Bank,  whether  incurred by the  Borrower as maker,
indorser,  drawer,  acceptor,  guarantor,   accommodation  party,  counterparty,
purchaser,  seller or  otherwise,  and whether due or to become due,  secured or
unsecured,  absolute or  contingent,  joint  and/or  several,  and  howsoever or
whensoever  acquired  by  the  Bank  (all  of  which  are  referred  to  as  the
"Obligations"),  and  irrespective  of the  genuineness,  validity,  regularity,
discharge,  release or enforceability of such Obligations,  or of any instrument
evidencing  any  of the  Obligations  or of any  collateral  therefor  or of the
existence or extent of such  collateral or of the obligations of the undersigned
under this guarantee.  The Obligations  shall include interest  accruing thereon
before or after the commencement of any insolvency, bankruptcy or reorganization
proceeding in respect of the Borrower or any other  guarantor of the Obligations
whether or not such interest is an allowable  claim in any such  proceeding  and
irrespective  of the discharge or release of the Borrower or any other guarantor
in such proceeding.

The  undersigned  assents  that the Bank may at any time and from  time to time,
either  before or after  the  maturity  thereof,  without  notice to or  further
consent of the undersigned,  extend the time of payment of,  exchange,  release,
substitute or surrender any  collateral  for,  renew or extend any of, or change
the amount of, the  Obligations  or increase the interest rate thereon,  and may
also make any  agreement  with the Borrower or with any other party to or person
liable  on  any of  the  Obligations  or any  guarantor  of or  hypothecator  of
collateral or other surety for such Obligations or interested  therein,  for the
extension, renewal, payment, compromise, discharge or release thereof, in whole
or in part,  or for any  modification  of the terms  thereof or of any agreement
between the Bank and the Borrower of any such other party or person,  without in
any way impairing or affecting this guarantee.

The  undersigned  agrees that this guarantee  shall not be impaired or otherwise
affected by any failure to call for, take,  hold,  protect or perfect,  continue
the  perfection of or enforce any security  interest in or other lien upon,  any
collateral  for the  Obligations,  or by an  failure to  exercise,  delay in the
exercising  or waiver of, or  forbearance  with  respect to, any right or remedy
available to the Bank with respect to the Obligations.

The  undersigned  acknowledges  that it has  derived  or  expects  to  derive  a
financial  or other  benefit  from each and  every  Obligation  incurred  by the
Borrower to the Bank.

The  undersigned  waives notice of the  acceptance of this  guarantee and of the
making  of any such  loans or  extensions  of credit  or the  incurrence  of any
Obligation,  presentment to or demand of payment from anyone  whomsoever  liable
upon any of the  Obligations,  protest,  notice or  presentment,  nonpayment  or
protest and notice of any sale or other  disposition  of collateral  security or
any default of any sort.

To  secure  the  liabilities  of  the  undersigned  under  this  guarantee,  the
undersigned  grants  to the  Bank a  security  interest  in and a lien  upon all
personal  property of the  undersigned or in which the  undersigned  may have an
interest  which is now or may at any time  hereafter come into the possession or
control of the Bank, or of any third party acting on behalf of the Bank, whether
for the express purpose of being used by the Bank as collateral  security or for
custody or for any other or different purpose,  including such personal property
as may be in transit by mail or carrier  for any  purpose or covered or affected
by any documents in the Bank's  possession or control,  or in the  possession or
control of any third party acting on behalf of the Bank, or any collateral which
secures any other  obligations of the  undersigned to the Bank. The  undersigned
authorizes the Bank in its  discretion,  at any time, to  appropriate  and apply
upon any of the  liabilities  of the  undersigned  under this guarantee any such
property of the  undersigned and to charge any of such  liabilities  against any
balance of any account standing to the credit of the undersigned on the books of
the Bank. To satisfy the  liabilities of the  undersigned  under this guarantee,
the Bank shall have,  in addition to all other  rights and  remedies  allowed by
law,  the rights and  remedies of a secured  party under the Uniform  Commercial
Code  and  without  limiting  the  generality  of the  foregoing,  the  Bank may
immediately,  without demand of  performance  and without notice of intention to
sell  or  otherwise  dispose  of or of the  time  or  place  of  sale  or  other
disposition  or of  redemption  or other  notice  or  demand  whatsoever  to the
undersigned,  all of which are expressly waived, to the extent permitted by law,
and without  advertisement,  sell at public or private  sale,  grant  options to
purchase or otherwise realize upon, in the State of New York, or elsewhere,  the
whole or from time to time any part of said collateral upon which the Bank shall
have a security  interest and lien as aforesaid,  and after  deducting  from the
proceeds  of sale or other  disposition  of the  said  collateral  all  expenses
(including  all  reasonable  expenses for legal services of every kind and other
expenses as set forth below),  the Bank shall apply the residue of such proceeds
towards  the payment of any of the  liabilities  of the  undersigned  under this
guarantee  in such  order as the Bank shall  elect,  the  undersigned  remaining
liable for any deficiency remaining unpaid after such application.  If notice of
any sale or other  disposition is required by law to be given,  the  undersigned
hereby  agrees  that  notice  sent at least  five  days  before  the time of any
intended  public  sale or of the time  after  which  any  private  sale or other
disposition of the said collateral is to be made, shall be reasonable  notice of
such sale or other disposition.

At any such sale or other disposition the Bank or any other person designated by
the Bank may itself  purchase  the whole or any part of the  collateral  sold or
otherwise  disposed  of,  free from any right of  redemption  on the part of the
undersigned,  which right, to the extent  permitted by law, is hereby waived and
released.

The  undersigned  agrees to pay on  demand,  all  expenses  (including,  but not
limited to, reasonable  attorneys' fees and expenses,  whether or not litigation
is commenced,  and cost of any insurance and payment of taxes or other  charges)
of, or incidental to, the custody,  care,  sale or collection of, or realization
upon, any of the said collateral.

This  is  a   continuing   guarantee   and  shall   apply  to  all   Obligations
notwithstanding  that at any particular time any or all of the Obligations shall
have been paid in full. This guarantee shall remain in full force and effect and
be binding upon the undersigned,  and the undersigned's  successors and assigns,
until written notice of its  revocation  shall actually be received by the Bank.
No such  revocation  shall release the  undersigned  or affect in any manner the
rights,  remedies,  powers,  security interests and liens of the Bank under this
guarantee with respect to any of the Obligations  which shall have been created,
contracted,  assumed  or  incurred  prior to actual  receipt by the Bank of such
written  notice of  revocation  and any  renewals or  extensions  thereof or any
Obligations which shall have been created, contracted, assumed or incurred after
actual receipt of such written notice pursuant to any agreement  entered into by
the Bank prior to actual  receipt of such  written  notice and any  renewals  or
extensions  thereof.  Any such  revocation by one of the  undersigned  shall not
affect the continuing liabilities hereunder of such of the undersigned as do not
give  notice of  revocation.  If any on the  present or future  Obligations  are
guaranteed by persons, partnerships, limited liability companies or corporations
in addition to the undersigned,  the death,  release or discharge in whole or in
part, or the  bankruptcy,  liquidation  or  dissolution  of one or more of them,
shall not  discharge or affect the  liabilities  of the  undersigned  under this
guarantee.

This guarantee  shall continue to be effective,  or shall be reinstated,  as the
case may be, if at any time  payment of all or any part of any payment of any of
the Obligations is rescinded or must be restored or returned by the Bank whether
under any insolvency,  bankruptcy,  receivership or reorganization proceeding or
otherwise.

This  guarantee may be assigned by the Bank and its benefits  shall inure to the
successors, indorsees and assigns of the Bank.

This  guarantee  is a guarantee of payment and not of  collection,  and the Bank
shall be under no  obligation  to take any action  against  the  Borrower or any
other  person  liable with  respect to any of the  Obligations  or resort to any
collateral  security  securing  any of the  Obligation  or this  guarantee  as a
condition  precedent to the  undersigned  being obligated to make payment and to
perform as agreed herein.  The  undersigned  hereby waives any right to claim or
interpose  any  defense,  counterclaim  or offset of any nature and  description
which it may have or which may exist  between and among the Bank,  the  Borrower
and/or the undersigned or to seek injunctive relief.

Promptly  upon the  Bank's  request,  the  undersigned  agrees to  furnish  such
information  (including financial statements and tax returns of the undersigned)
to the Bank and to permit the Bank to inspect  and make  copies of its books and
records, as the Bank shall reasonable request from time to time.

The  undersigned  authorizes the Bank to date this guarantee and to complete any
blank space herein according to the terms upon which this guarantee was given.

Any notice to the Bank shall be  effective  only upon receipt by the Bank and if
directed to the Bank at its banking  office set forth above or any other address
hereafter specified by written notice from the Bank to the undersigned.

Until  such  time  as the  Bank  shall  have  received  payment  in full in cash
satisfaction of all of the Obligations,  the undersigned  waives any right to be
subrogated  to the rights of the Bank with respect to the  Obligations,  and the
undersigned  waives any right to and agrees that it will not  institute  or take
any  action  against  the  Borrower  seeking   contribution,   reimbursement  or
indemnification  by the  Borrower  with  respect  to  any  payment  made  by the
undersigned to the Bank hereunder.

The  undersigned  agrees  to pay all  costs and  expenses  incurred  by the Bank
incidental to or in any way relating to the enforcement of the Obligation or the
obligations of the undersigned  hereunder or the protection of the rights of the
Bank  hereunder or with  respect to any of the  Obligations  including,  but not
limited to, reasonable  attorneys' fees and expenses,  whether or not litigation
is commenced.

Every  provision of this  guarantee is intended to be severable;  if any term or
provision of this guarantee shall be invalid,  illegal or unenforceable  for any
reason  whatsoever,  the validity, legality and enforceability of the remaining
provision hereof shall not in any way be affected or impaired thereby.

No failure on the part of the Bank to exercise, and no delay in exercising,  any
right,  remedy or power hereunder  shall operate as a waiver thereof,  nor shall
any  single  or  partial  exercise  by the Bank of any  right,  remedy  or power
hereunder  preclude any other or future exercise  thereof or the exercise of any
other fight, remedy or power.

Each and every right,  remedy and power hereby granted to the Bank or allowed it
by law or other  agreement  shall be  cumulative  and not exclusive of any other
right,  remedy or power,  and may be  exercised by the Bank at any time and from
time to time.

This guarantee contains the entire agreement and understanding  between the Bank
and the undersigned with respect to the subject matter hereof and supersedes all
prior agreements and understanding  relating to the subject matter hereof.  This
guarantee may not be amended,  and compliance  with its terms may not be waived,
orally or by course of dealing,  but only by a writing  signed by an  authorized
officer of the Bank.

Until cash payment in full of the  obligation,  the liability of the undersigned
under this guarantee shall not be released.


IF THE UNDERSIGNED IS A CORPORATION:

The  undersigned  represents and warrants that the  undersigned is a corporation
duly  organized,  validly  existing- and in good standing  under the laws of the
state of' its  incorporation;  that the execution,  delivery and  performance of
this guarantee are within the undersigned's  corporate powers and have been duly
authorized by all necessary action of its board of directors arid  shareholders;
and that each person  executing  this guarantee has the authority to execute and
deliver this guarantee on behalf of the undersigned.

IF THE UNDERSIGNED IS A LIMITED LIABILITY COMPANY:

The  undersigned  represents  and  warrants  that the  undersigned  is a limited
liability  company duly organized,  validly  existing and in good standing under
the laws of the state of' its  organization;  that the  execution,  delivery and
performance  of this guarantee are within the  undersigned's  company powers and
have been duly authorized by all necessary action of its members;  and that each
person  executing  this  guarantee has the authority to execute and deliver this
guarantee on behalf of the undersigned.

IF THE UNDERSIGNED IS A PARTNERSHIP:

The  undersigned  represents and warrants that the  undersigned is a partnership
duly formed under the laws of the state of' its  formation;  that the execution,
delivery  and  performance  of  this  guarantee  are  within  the  undersigned's
partnership  powers and have been duly authorized by all necessary action of its
partners and do not contravene the provision of its partnership  agreement;  and
that each person  executing  this  guarantee  has the  authority  to execute and
deliver this guarantee on behalf of the undersigned.

THIS  GUARANTEE  SHALL  BE  CONSTRUED  AND  INTERPRETED,  AND  ALL  RIGHTS  AND
OBLIGATIONS  HEREUNDER  SHALL BE DETERMINED,  IN ACCORDANCE WITH THE LAWS OF THE
STATE OF NEW YORK WITHOUT  REGARD TO PRINCIPLES OF CONFLICT OF LAWS.  UNLESS THE
TEXT OTHERWISE REQUIRES, ALL TERMS USED HEREIN SHALL HAVE THE MEANINGS SPECIFIED
IN THE UNIFORM COMMERCIAL CODE. THE UNDERSIGNED  SUBMITS TO THE JURISDICTION OF
STATE AND FEDERAL  COURTS  LOCATED IN THE CITY AND STATE OF NEW YORK IN PERSONAM
AND AGREES THAT ALL ACTIONS AND PROCEEDINGS  RELATING  DIRECTLY OR INDIRECTLY TO
THIS  GUARANTEE  SHALL  BE  LITIGATED  ONLY IN SAID  COURTS  OR  COURTS  LOCATED
ELSEWHERE AS THE BANK MAY SELECT AND THAT SUCH COURTS ARE CONVENIENT FORUMS. THE
UNDERSIGNED  WAIVES PERSONAL  SERVICE UPON IT AND CONSENTS TO SERVICE OF PROCESS
OUT OF SAID COURTS BY MAILING A COPY  THEREOF TO IT BY  REGISTERED  OR CERTIFIED
MAIL.

THE  UNDERSIGNED  AND THE BANK WAIVE THE RIGHT TO TRIAL BY JURY IN ANY ACTION OR
PROCEEDING BASED UPON,  ARISING OUT OF OR IN ANY WAY CONNECTED TO THIS GUARANTEE
OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY OR THE OBLIGATIONS.

IN WITNESS HEREOF, this guarantee has been executed by the undersigned as of the
date first written above.


NAME OF GUARANTOR:         James L. Kehoe
                                    12 Lenape Lane
                                    Salisbury Mills, NY 12577


SIGNATURE OF GUARANTOR
OR AUTHORIZED SIGNER:-/s/James L. Kehoe
If Authorize Signer
Name:  James L. Kehoe


ACKNOWLEDGEMENT FOR INDIVIDUAL

State of New York
County of Ulster

On the 15th day of February,  1999, before me personally came James L. Kehoe, to
me  known to be the  individual  described  in and who  executed  the  foregoing
instrument, and acknowledged that (s)he executed the same

/s/ Claudine Y. Corda
Claudine Y. Corda
Notary Public State of New York
Reg No. 01C06005915
Qualified in Dutchess County
Commission Expires 4/20/2000


                             LIMITATION OF LIABILITY
(the following provisions shall be effective only if executed by a duly
 authorized officer of the Bank)

Notwithstanding  the aggregate amount of the Obligations which may become due to
the Bank from the Borrower at any time and from time to time,  the  liability of
the  guarantor  under  this  guarantee  shall  be  limited  to the  sum of (i) $
_________________  (hereinafter referred to as the "Maximum Amount"),  (ii) such
portion of the interest, legal expenses,  insurance, taxes and other charges and
expenses as are  provided for in the  instruments  or other  documents  (if any)
evidencing  the  Obligations  of the Borrower as the Maximum Amount bears to the
aggregate principal amount of all Obligations of the Borrower to the Bank at the
time the Bank  demands  payment  under  this  guarantee  and (iii) all  expenses
(including, but not limited to, reasonable attorneys' fees and expenses, whether
or not  litigation  is  commenced)  in any way  relating to the  enforcement  or
protection  of the rights of the Bank under this  guarantee.  It is  understood,
however, that the Obligations of the Borrower to the Bank may at any time exceed
the Maximum Amount without affecting the liabilities of the guarantor under this
guarantee.

BANK OFFICER
<PAGE>
Exhibit10(f)  Bank of New York Line of Credit

THE
BANK OF
NEW                           MASTER PROMISSORY NOTE
YORK                               (PRIME RATE)

$ 300,000.00                                                   February 15, 1999


FOR VALUE RECEIVED,  the undersigned (the "Borrower")  hereby promises to pay to
the  order  of  THE  BANK  OF NEW  YORK  (the  "Bank")  at its  285  Main  Mall,
Poughkeepsie,  New York office,  the  principal  sum of THREE  HUNDRED  THOUSAND
Dollars  ($300,000.00)  or the aggregate unpaid principal amount of all advances
made by the Bank to the Borrower (which  aggregate unpaid principal amount shall
be equal to the  amount  duly  indorsed  and set  forth  opposite  the date last
appearing on the schedule attached to this note), whichever is less.
Advances evidenced by this note shall be payable ON DEMAND.

The  Borrower  agrees to pay  interest on the unpaid  principal  balance of each
advance  evidenced hereby from the date such advance is made at a rate per annum
equal to the Prime Rate plus 2.0%,  but not to exceed the maximum rate permitted
by law. If any payment  which is to be made  hereunder is not paid when due, the
Borrower  agrees to pay interest on such payment,  payable on demand,  at a rate
per annum equal to the rate specified in the preceding sentence plus 2%, but not
to exceed the maximum rate  permitted by law.  "Prime Rate" shall mean,  for any
day, the prime commercial  lending rate of the Bank as publicly  announced to be
in effect  from time to time,  such rate to be adjusted  automatically,  without
notice,  on the  effective  date  of any  change  in  such  rate.  The  Borrower
acknowledges  that the Prime Rate is not the  lowest  rate at which the Bank may
make loans or other  extensions  of credit.  Interest  shall be  computed on the
basis of a 360 day year for the  actual  number  of days  elapsed  and  shall be
payable on the ____ day of each month and at maturity of each advance  evidenced
by this note (whether by acceleration or otherwise).

If any payment of  principal  of or interest on the  advances  evidenced by this
note  becomes due and  payable on a  Saturday,  Sunday or other day on which the
Bank is  permitted or required by law to be closed,  then such payment  shall be
extended to the next  succeeding  business day, and interest shall be payable at
the rate set forth above during such extension.

Advances evidenced by this note may be prepaid at any time without penalty,  but
with interest on the amount being prepaid through the date of prepayment.

If the Bank shall make a new advance on a day on which the Borrow is to repay an
advance hereunder,  the Bank shall apply the proceeds of the new advance to make
such repayment and only the amount by which the amount being advanced exceed the
amount being repaid shall be made  available to the Borrower in accordance  with
the terms of this note.

The Borrow authorizes the Bank to accept oral (including telephonic) and written
(including   facsimile)   instructions   from  the  Borrower  or  an  authorized
representative  of the  Borrower  to make an advance  hereunder  or receive  any
payment hereof and to indorse on the schedule  attached hereto the amount of all
advances  hereunder and all principal  payments hereof received by the Bank. The
Borrower agrees that the Bank may rely on  instructions  believed by the Bank to
be genuine and given by the  Borrower  or an  authorized  representative  of the
Borrower.

The Bank is authorized to charge any deposit account of the Borrower  maintained
at the Bank for each principal  prepayment hereof on the date made, and for each
principal  payment and for each  interest  payment due hereunder on the due date
thereof.  The Bank shall credit the Borrower's deposit account maintained at the
Bank in the amount of each advance hereunder on the date of such advance,  which
credit  will be  confirmed  to the  Borrower  by  standard  advice  of credit or
notation in the monthly  statement sent to the Borrower in connection  with such
account.  The  Borrower  agrees that the actual  crediting  of the amount of the
advance to the Borrower's deposit account shall constitute  conclusive  evidence
that the advance was made, and neither the failure of the Bank to indorse on the
schedule  attached  hereto the amount of the advance nor the failure of the Bank
to  forward  an advice of credit to the  Borrower  or note such  advance  in the
monthly  statement sent to the Borrower shall effect the Borrower's  obligations
hereunder.

The Bank shall have a lien on the  balances of the  Borrower now or hereafter on
deposit  with or held as  custodian  by the Bank and the Bank  shall  have  full
authority to set off such balances  against the  indebtedness  evidenced by this
note or any other  Obligation  (which term shall include any and all present and
future  obligations or liabilities of the Borrower as maker,  indorser,  drawer,
acceptor,  guarantor,  accommodation party, counterparty,  purchaser,  seller or
otherwise,  and whether due or to become due, secured or unsecured,  absolute or
contingent,  joint and/or several,  and howsoever and whensoever acquired by the
Bank) and may at any time, without notice, to the extent permitted by law, apply
the same to the  advances  evidenced  by this  note or such  other  Obligations,
whether due or not.

All obligations of the Borrower to the Bank under this note are secured pursuant
to the terms of any security  agreement executed by the Borrower in favor of the
Bank dated of even date  herewith as such  agreement  may be amended or modified
from time to time and any other security  agreement that the Borrower shall have
executed  or shall at any time  execute  in favor of the  Bank,  and the Bank is
entitled to all the benefits thereof.

The  Borrower  acknowledges  that the  advances  evidence  hereby are payable on
demand  and  payment  thereof  may be  demanded  by the Bank at any time for any
reason in the sole and absolute discretion of the Bank.

All advances  evidenced  hereby together with all accrued interest thereon shall
become   immediately  and  automatically   due  and  payable,   without  demand,
presentment,  protest or notice of any kind, upon the commencement by or against
the  Borrower,  any  guarantor of this note or any  hypothecator  of  collateral
securing this note of a case or proceeding  under any bankruptcy,  insolvency or
other law relating to the relief of debtors,  the  readjustment,  composition or
extension of indebtedness or reorganization or liquidation.

The  Borrower  waives  presentment,  demand,  protest  and  notice  of  protest,
non-payment or dishonor of this note.

The  Borrower  agrees  to pay  all  costs  and  expenses  incurred  by the  Bank
incidental  to or  in  any  way  relating  to  the  Bank's  enforcement  of  the
obligations of the Borrower  hereunder or the protection of the Bank's rights in
connection herewith,  including,  but not limited to, reasonable attorneys' fees
and expenses, whether or not litigation is commenced.

Promptly  upon  the  Bank's  request,   the  Borrower  agrees  to  furnish  such
information (including, without limitation, financial statements and tax returns
of the  Borrower)  to the Bank and to permit the Bank to inspect and make copies
of its books and  records,  as the Bank shall  reasonably  request  from time to
time.

So long as any  obligation of the Borrower to the Bank is or may be  outstanding
and  unpaid,  the  Borrower  agrees  that it will not grant,  without  the prior
written  consent  of the  Bank,  a  security  interest  in,  a lien  upon  or an
assignment  of, any of its current  assets (as  classified  in  accordance  with
generally accepted accounting  principles) now owned or hereafter  acquired,  to
secure any  obligation  for the payment of borrowed  money  indebtedness  except
indebtedness owed to the Bank.

The Borrower waives any right to claim or interpose any  counterclaim or set-off
of any  kind  in any  litigation  relating  to  this  note  or the  transactions
contemplated hereby.

This note may not be amended.  and compliance  with its terms may not be waived,
orally or by course of dealing,  but only by a writing  signed by an  authorized
officer of the Bank.

This note may be assigned or indorsed by the Bank and its  benefits  shall inure
to the successors, indorsees and assigns of the Bank.

The  Borrower  authorizes  the Bank to date this note and to complete  any blank
space herein according to the terms upon which said advances were granted.

No failure on the part of the Bank to exercise, and no delay in exercising,  any
right,  remedy or power hereunder  shall operate as a waiver thereof,  nor shall
any  single  or  partial  exercise  by the Bank of any  right,  remedy  or power
hereunder  preclude any other or future exercise  thereof or the exercise of any
other right, remedy or power.

Each and every right,  remedy and power hereby granted to the Bank or allowed it
by law or other  agreement  shall be  cumulative  and not exclusive of any other
right,  remedy or power,  and may be  exercised by the Bank at any time and from
time to time.

Every  provision  of this  note is  intended  to be  severable;  if any  term or
provision  of this note  shall be  invalid,  illegal  or  unenforceable  for any
reason, the validity,  legality and  enforceability of the remaining  provisions
hereof shall not in any way be affected or impaired thereby.

IF THE BORROWER IS A CORPORATION:

The Borrower  represents  and warrants that the Borrower is a  corporation  duly
organized, validly existing and in good standing under the laws of the state of'
its incorporation and is duly qualified to do business in the State of New York;
that the  execution,  delivery  and  performance  of this  note are  within  the
Borrower's  corporate  powers  and have been duly  authorized  by all  necessary
action  of its  board  of  directors  and  shareholders;  and that  each  person
executing this note has the authority to execute and deliver this note on behalf
of the Borrower.

IF THE BORROWER IS A LIMITED LIABILITY COMPANY:

The Borrower  represents  and warrants that the Borrower is a limited  liability
company duly organized, validly existing- and in good standing under the laws of
the state of' its organization and is duly qualified to do business in the State
of New York;  that the  execution,  delivery  and  performance  of this note are
within  the  Borrower's  company  powers  and have been duly  authorized  by all
necessary  action of its members;  and that each person  executing this note has
the authority to execute and deliver this note on behalf of the Borrower.

IF THE BORROWER IS A PARTNERSHIP:

The Borrower  represents  and warrants that the Borrower is a  partnership  duly
formed under the laws of the state of' its formation and is duly qualified to do
business in the State of New York; that the execution,  delivery and performance
of this note are within  the  Borrower's  partnership  powers and have been duly
authorized by all  necessary  action of its partners and do not  contravene  the
provisions of its  partnership  agreement;  and that each person  executing this
note has the  authority  to  execute  and  deliver  this  note on  behalf of the
Borrower.

THE PROVISIONS OF THIS NOTE SHALL BE CONSTRUED AND  INTERPRETED,  AND ALL RIGHTS
AND OBLIGATIONS HEREUNDER  DETERMINED,  IN ACCORDANCE WITH THE LAWS OF THE STATE
OF NEW YORK WITHOUT  REGARD TO THE  PRINCIPLES OF CONFLICT OF LAWS. THE BORROWER
SUBMITS TO THE  JURISDICTION OF STATE AND FEDERAL COURTS LOCATED IN THE CITY AND
STATE OF NEW YORK IN  PERSONAM  AND  AGREES  THAT ALL  ACTIONS  AND  PROCEEDINGS
RELATED  DIRECTLY OR  INDIRECTLY  TO THIS NOTE SHALL BE  LITIGATED  ONLY IN SAID
COURTS OR COURTS LOCATED  ELSEWHERE AS SELECTED BY THE BANK AND THAT SUCH COURTS
ARE CONVENIENT FORUMS. THE BORROWER WAIVES PERSONAL SERVICE UPON IT AND CONSENTS
TO SERVICE OF PROCESS BY MAILING A COPY THEREOF TO IT BY REGISTERED OR CERTIFIED
MAIL.

THE  BORROWER  AND THE BANK  WAIVE THE  RIGHT TO TRIAL BY JURY IN ANY  ACTION OR
PROCEEDING  BASED UPON,  ARISING OUT OF OR IN ANY WAY  CONNECTED TO THIS NOTE OR
THE TRANSACTIONS CONTEMPLATED HEREBY.


Name of Borrower:      Sono-Tek Corporation
Address of Borrower:   2012 Route 9W, Bldg. 3
                       Milton, NY  12547

Signature of Borrower
or Authorized Signer:  /s/James L. Kehoe
Name:                  James L. Kehoe
Title:                 CEO

Signature of Borrower
or Authorized Signer:  /s/Kathleen N. Martin
Name:                  Kathleen N. Martin
Title:                 CFO, Treasurer
<PAGE>
Exhibit 23(a)  Independent Auditors' Consent

INDEPENDENT AUDITORS' CONSENT


We consent to the  incorporation  by reference  in  Registration  Statement  No.
333-60481  on Form S-8 of our report  dated May 5, 1999 (May 13, 1999 as to Note
16) appearing in the Annual Report on Form 10-K of Sono-Tek  Corporation for the
year ended February 28, 1999.

DELOITTE & TOUCHE LLP
Stamford, Connecticut
May 28, 1999

<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0000806172
<NAME>                        Sono-Tek Corporation
<MULTIPLIER>                                   1
<CURRENCY>                                     US Dollars

<S>                             <C>
<PERIOD-TYPE>                   Year
<FISCAL-YEAR-END>                              FEB-28-1999
<PERIOD-START>                                 MAR-01-1998
<PERIOD-END>                                   FEB-28-1999
<EXCHANGE-RATE>                                        1
<CASH>                                            70,051
<SECURITIES>                                           0
<RECEIVABLES>                                    264,217
<ALLOWANCES>                                       6,000
<INVENTORY>                                      787,200
<CURRENT-ASSETS>                               1,163,507
<PP&E>                                           127,892
<DEPRECIATION>                                   407,486
<TOTAL-ASSETS>                                 1,335,649
<CURRENT-LIABILITIES>                            890,591
<BONDS>                                                0
                                  0
                                            0
<COMMON>                                          62,817
<OTHER-SE>                                       335,865
<TOTAL-LIABILITY-AND-EQUITY>                   1,335,649
<SALES>                                        2,902,951
<TOTAL-REVENUES>                               2,902,951
<CGS>                                          1,616,617
<TOTAL-COSTS>                                  1,616,617
<OTHER-EXPENSES>                                       0
<LOSS-PROVISION>                                       0
<INTEREST-EXPENSE>                                60,448
<INCOME-PRETAX>                                 (810,702)
<INCOME-TAX>                                           0
<INCOME-CONTINUING>                                    0
<DISCONTINUED>                                         0
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                    (810,702)
<EPS-BASIC>                                       (.18)
<EPS-DILUTED>                                       (.18)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission